[go: up one dir, main page]

US20160157515A1 - Smokeless tobacco pouch - Google Patents

Smokeless tobacco pouch Download PDF

Info

Publication number
US20160157515A1
US20160157515A1 US14/561,736 US201414561736A US2016157515A1 US 20160157515 A1 US20160157515 A1 US 20160157515A1 US 201414561736 A US201414561736 A US 201414561736A US 2016157515 A1 US2016157515 A1 US 2016157515A1
Authority
US
United States
Prior art keywords
water
pouch
modifying agent
composition
pouched product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/561,736
Other languages
English (en)
Inventor
Paul Stuart Chapman
David Troy Turfler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RJ Reynolds Tobacco Co
Original Assignee
RJ Reynolds Tobacco Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RJ Reynolds Tobacco Co filed Critical RJ Reynolds Tobacco Co
Priority to US14/561,736 priority Critical patent/US20160157515A1/en
Assigned to R.J. REYNOLDS TOBACCO COMPANY reassignment R.J. REYNOLDS TOBACCO COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHAPMAN, PAUL STUART, TURFLER, DAVID TROY
Priority to CN202211208329.8A priority patent/CN115517405A/zh
Priority to DK15816994.6T priority patent/DK3226700T3/da
Priority to EP15816994.6A priority patent/EP3226700B1/fr
Priority to CN201580075231.1A priority patent/CN107205471A/zh
Priority to PCT/US2015/063592 priority patent/WO2016090075A1/fr
Priority to JP2017529638A priority patent/JP6854760B2/ja
Priority to EP24179307.4A priority patent/EP4442128A1/fr
Publication of US20160157515A1 publication Critical patent/US20160157515A1/en
Priority to JP2021041038A priority patent/JP7485628B2/ja
Priority to US17/363,174 priority patent/US11344057B2/en
Priority to US17/737,680 priority patent/US11832640B2/en
Priority to US18/389,152 priority patent/US20240074481A1/en
Priority to JP2024074696A priority patent/JP2024105405A/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F23/00—Cases for tobacco, snuff, or chewing tobacco
    • A24F23/02—Tobacco pouches
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/282—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by indirect addition of the chemical substances, e.g. in the wrapper, in the case
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/42—Treatment of tobacco products or tobacco substitutes by chemical substances by organic and inorganic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Definitions

  • the present disclosure relates to products made or derived from tobacco, or that otherwise incorporate tobacco, and are intended for human consumption.
  • the disclosure relates to a fleece that may be combined with smokeless tobacco to form a pouched product suitable for oral use.
  • Products commonly referred to as “snus,” for example, comprise ground tobacco materials incorporated within sealed pouches.
  • Representative types of snus products have been manufactured in Europe, particularly in Sweden, by or through companies such as Swedish Match AB (e.g., for brands such as General, Ettan, Goteborgs Rape and Grovsnus); Fiedler & Lundgren AB (e.g., for brands such as Lucky Strike, Granit, Krekt and Mocca); JTI Sweden AB (e.g., for brands such as Gustavus) and Rocker Production AB (e.g., for brands such as Rocker).
  • Swedish Match AB e.g., for brands such as General, Ettan, Goteborgs Rape and Grovsnus
  • Fiedler & Lundgren AB e.g., for brands such as Lucky Strike, Granit, Krekt and Mocca
  • JTI Sweden AB e.g., for brands such as Gustavus
  • Rocker Production AB e.
  • snus products can be manufactured using equipment such as that available as SB 51-1/T, SBL 50 and SB 53-2/T from Merzmaschinen GmBH.
  • Certain types of product employing pouches or sachets have been employed to contain nicotine, such as those used for nicotine replacement therapy (NRT) types of products (e.g., a pharmaceutical product distributed under the tradename ZONNIC® by Niconovum AB).
  • NRT nicotine replacement therapy
  • a pharmaceutical product distributed under the tradename ZONNIC® by Niconovum AB e.g., a pharmaceutical product distributed under the tradename ZONNIC® by Niconovum AB.
  • NRT nicotine replacement therapy
  • WO 2010/031552 to Axelsson et al. and WO 2012/134380 to Nilsson which are incorporated herein by reference.
  • Tobacco is known to include a number of constituents that may be more desirable or less desirable for release therefrom in a smokeless tobacco composition. It would be desirable to provide a smokeless tobacco product that is configured to alter the amount of certain constituents that may be released therefrom during use.
  • the present invention relates to products for oral delivery of one or more components of a composition. More particularly, a composition may be retained within a fleece—i.e., a water-permeable fabric—in the form of a pouch, and the delivery of the one or more components of the composition may be modified, such as to partially or substantially completely prevent release of one or more components from the fleece.
  • a fleece i.e., a water-permeable fabric
  • the present disclosure relates to a pouched product.
  • the pouched product can comprise a water-permeable fabric pouch formed so as to define a cavity therein.
  • a composition can be contained within the cavity of the water-permeable fabric pouch, and the composition can comprise one or more releasable components that are released from the composition under mouth conditions and that are capable of movement through the water-permeable fabric pouch.
  • a release modifying agent can also be included within the cavity or be otherwise combined with the water-permeable fabric, and the release modifying agent can be adapted to react with at least one of the one or more releasable components in the composition and thereby modify the release thereof from the water-permeable fabric pouch.
  • the pouched product can be defined by one or more particular elements, characteristics, or functions.
  • the pouched product can be further defined by one or more of the following descriptions in any combination.
  • the fabric pouch can be formed of a nonwoven web of fibers.
  • the fabric can comprise natural fibers.
  • the fabric can comprise synthetic fibers.
  • the fabric can comprise cellulosic fibers.
  • the fabric can comprise a heat sealable binder fiber.
  • the release modifying agent can form a part of the fabric.
  • the water-permeable fabric pouch can be infused with the release modifying agent.
  • the release modifying agent can be adsorbed or absorbed by at least a portion of the water-permeable fabric pouch.
  • the water-permeable fabric pouch can comprise a filter media.
  • the release modifying agent can be admixed with the composition contained within the cavity of the water-permeable fabric pouch.
  • the release modifying agent can be adapted to bind with at least one of the one or more releasable components in the composition so as to substantially prevent the release of at least a portion of the bound component from the water-permeable fabric pouch.
  • the release modifying agent can be in an encapsulated form.
  • the release modifying agent can be adapted to chemically or physically modify at least one of the one or more releasable components in the composition prior to or during release thereof from the water-permeable fabric pouch.
  • the release modifying agent can be adapted to react with a component selected from the group consisting of acetaldehyde, arsenic, benzo[a]pyrene, cadmium, crotonaldehyde, formaldehyde, nicotine, nicotine-derived nitrosamine ketone (NNK), N-nitrosonornicotine (NNN), derivatives thereof, decomposition products thereof, precursors thereof, and combinations thereof.
  • a component selected from the group consisting of acetaldehyde, arsenic, benzo[a]pyrene, cadmium, crotonaldehyde, formaldehyde, nicotine, nicotine-derived nitrosamine ketone (NNK), N-nitrosonornicotine (NNN), derivatives thereof, decomposition products thereof, precursors thereof, and combinations thereof.
  • the release modifying agent can be selected from the group consisting of adsorbents, absorbents, molecularly imprinted polymers (MIPS), non-molecularly imprinted polymers (NIPS), botanicals, antioxidants, chelating agents, cyclodextrins, and combinations thereof.
  • MIPS molecularly imprinted polymers
  • NIPS non-molecularly imprinted polymers
  • botanicals antioxidants
  • chelating agents cyclodextrins, and combinations thereof.
  • composition within the cavity of the water-permeable fabric pouch can comprise at least one of a particulate tobacco material, nicotine, particulate non-tobacco material treated to contain nicotine and/or flavoring agents, and fibrous plant material treated to contain a tobacco extract.
  • FIG. 1 is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein according to an embodiment of the present disclosure
  • FIG. 2 is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein and including a release modifying agent according to an embodiment of the present disclosure
  • FIG. 3 is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein and including a release modifying agent in particulate form according to an embodiment of the present disclosure
  • FIG. 4 is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein and including a release modifying agent within a separate fleece container according to an embodiment of the present disclosure
  • FIG. 5A is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein and including an encapsulated release modifying agent according to an embodiment of the present disclosure
  • FIG. 5B is an illustration of a pouched product formed of a water-permeable fabric pouch having a composition therein and including a plurality of capsules enclosing a release modifying agent according to an embodiment of the present disclosure.
  • a pouched product configured for insertion into the mouth of a user.
  • the pouched product can comprise a water-permeable fabric pouch as an outer element and a composition comprising one or more releasable components as an inner element.
  • the water-permeable fabric pouch particularly can define a cavity in which the composition can be situated.
  • the composition positioned within the pouch can be any composition containing one or more releasable components that are capable of movement through the water-permeable fabric pouch.
  • Non-limiting, exemplary compositions include tea or coffee materials (e.g., in the context of a beverage pouch adapted for brewing or steeping) or compositions adapted for oral use (e.g., tobacco-derived products such as snus or nicotine replacement therapy products).
  • the composition within the cavity of the pouch can comprise at least one of a particulate tobacco material, nicotine, particulate non-tobacco material (e.g., microcrystalline cellulose) treated to contain nicotine and/or flavoring agents, and fibrous plant material (e.g., beet pulp fiber) treated to contain a tobacco extract.
  • the releasable component in the composition can be a component that is released from the composition under mouth conditions.
  • Mouth conditions can encompass one or more characteristics (in any combination) associated with the presence of an item in the mouth of a user.
  • mouth conditions can include any combination of temperature, moisture, and pH typically found in the mouth of a human as well as the shear, compression, and other mechanical forces that may be applied by the teeth during chewing.
  • Mouth conditions particularly can relate to being in contact with saliva.
  • saliva in the mouth may at least partially solubilize a releasable component so that the component is freed from the composition for potential movement through the water-permeable fabric pouch and into the mouth of the user.
  • Mouth conditions can include conditions wherein a releasable component is solubilized in a solvent so as to be mobilized from the composition for free movement via the solvent, including movement through the fleece (i.e., the water-permeable fabric).
  • mouth conditions can be viewed as a generic term whereby the pouched product is contacted with any aqueous solvent.
  • FIG. 1 An exemplary embodiment of a pouched product 100 is shown in FIG. 1 and can comprise a water-permeable fabric 120 in the form of a pouch which contains a composition 115 adapted for oral use.
  • a composition 115 adapted for oral use.
  • the orientation, size, and type of the water-permeable fabric pouch and the type and nature of the composition adapted for oral use that are illustrated herein are not construed as limiting thereof.
  • a moisture-permeable packet or pouch can act as a container for use of the composition within.
  • the composition/construction of such packets or pouches, such as the water-permeable fabric pouch 120 in the embodiment illustrated in FIG. 1 may be varied as noted herein.
  • suitable packets, pouches, or containers of the type used for the manufacture of smokeless tobacco products which can be suitable for use according to the present disclosure are available under the tradenames CatchDry, Ettan, General, Granit, Goteborgs Rape, Grovsnus White, Metropol Kaktus, Mocca Anis, Mocca Mint, Mocca Wintergreen, Kicks, Probe, Prince, Skruf, and TreAnkrare.
  • a pouch type of product similar in shape and form to various embodiments of a pouched product described herein is commercially available as ZONNIC (distributed by Niconovum AB). Additionally, pouch type products generally similar in shape and form to various embodiments of a pouched product are set forth as snuff bag compositions E through J in Example 1 of PCT WO 2007/104573 to Axelsson et al., which is incorporated herein by reference, which are produced using excipient ingredients and processing conditions that can be used to manufacture pouched products as described herein.
  • a water-permeable fabric useful as a pouch to house a composition adapted for oral use can comprise a nonwoven web.
  • the user can place one pouched product containing the composition adapted for oral use in the mouth of the human subject/user.
  • the releasable components preferably are capable of movement through the water-permeable fabric pouch and into the mouth of the user.
  • the pouch preferably is not swallowed.
  • the pouch may be subject to chewing but is preferably not chewed so as to substantially tear or otherwise perforate the pouch and allow the composition to spill into the mouth.
  • the user is provided with flavor and satisfaction, and is not required to spit out any portion of the product.
  • a time suitable for use/enjoyment by the user e.g., about 10 minutes to about 60 minutes, typically about 15 minutes to about 45 minutes
  • substantial amounts of the releasable components may be ingested by the human subject, and the pouch may be removed from the mouth of the human subject for disposal.
  • the pouch can be formed of any material that is suitable for use in the human mouth and that is sufficiently moisture-permeable, liquid-permeable, and/or water-permeable so as to allow for movement of the releasable components from the composition contained therein, particularly when in contact with saliva.
  • water-permeable particularly includes saliva-permeable.
  • the pouch material may be of a type that may be considered to be similar in character to the mesh-like type of material that is used for the construction of a tea bag.
  • Components of the loosely arranged composition adapted for oral use readily diffuse through the pouch and into the mouth of the user (or into a surrounding environment, such as the fluid into which a pouched product may be placed, for example in embodiments wherein the pouched product may be a tea bag or the like).
  • Preferred fabric materials for the pouched products may be designed and manufactured such that under conditions of normal use, a significant amount of the releasable components of the composition permeate through the pouch prior to the time that the pouch undergoes loss of its physical integrity. If desired, flavoring ingredients, disintegration aids, and other desired components, may be incorporated within, or applied to, the pouch material.
  • the water-permeable fabric forming the pouch is generally suitable for containing, particularly in dry conditions, a composition that can be in a powdered, granular, shredded, or bulk solid form.
  • the water-permeable fabric also preferably contains the composition under mouth conditions while allowing movement therethrough of the releasable components (i.e., the solubilized components) of the composition.
  • the water-permeable fabric may have a basic structure that is adapted to retain solids above a certain particle size while allowing particles below the defined size that may be dispersed in saliva, as well as solubilized components of the composition, to move therethrough.
  • the pouched products described herein particularly may include a composition adapted for oral use that is a tobacco-containing composition and/or a nicotine-containing pharmaceutical composition. That is, the composition adapted for oral use can be contained within a container, such as a pouch or bag, such as the type commonly used for the manufacture of snus types of products (e.g., a sealed, moisture permeable pouch that is sometimes referred to as a “portion”).
  • a container such as a pouch or bag, such as the type commonly used for the manufacture of snus types of products (e.g., a sealed, moisture permeable pouch that is sometimes referred to as a “portion”).
  • Certain oral products of the disclosure will incorporate some form of a plant of the Nicotiana species, and most preferably, those compositions or products incorporate some form of tobacco.
  • the selection of the plant from the Nicotiana species can vary; and in particular, the types of tobacco or tobaccos may vary.
  • Tobaccos that can be employed include flue-cured or Virginia (e.g., K326), burley, sun-cured (e.g., Indian Kurnool and Oriental tobaccos, including Katerini, Prelip, Komotini, Xanthi and Yambol tobaccos), Maryland, dark, dark-fired, dark air cured (e.g., Passanda, Cubano, Jatin and Bezuki tobaccos), light air cured (e.g., North Wisconsin and Galpao tobaccos), Indian air cured, Red Russian and Rustica tobaccos, as well as various other rare or specialty tobaccos. Additional information on types of Nicotiana species suitable for use in the present invention can be found in US Pat. Appl. Pub. No. 2012/0192880 to Dube et al., which is incorporated by reference herein.
  • the portion or portions of the plant of the Nicotiana species used according to the present invention can vary. For example, virtually all of the plant (e.g., the whole plant) can be harvested, and employed as such. Alternatively, various parts or pieces of the plant can be harvested or separated for further use after harvest. For example, the leaves, stem, stalk, roots, lamina, flowers, seed, and various portions and combinations thereof, can be isolated for further use or treatment.
  • the plant material of the invention may thus comprise an entire plant or any portion of a plant of the Nicotiana species. See, for example, the portions of tobacco plants set forth in US Pat. Appl. Pub. Nos. 2011/0174323 to Coleman, III et al. and 2012/0192880 to Dube et al., which are incorporated by reference herein.
  • the tobacco material can be subjected to various treatment processes such as, refrigeration, freezing, drying (e.g., freeze-drying or spray-drying), irradiation, yellowing, heating, cooking (e.g., roasting, frying or boiling), fermentation, bleaching, or otherwise subjected to storage or treatment for later use.
  • treatment processes such as, refrigeration, freezing, drying (e.g., freeze-drying or spray-drying), irradiation, yellowing, heating, cooking (e.g., roasting, frying or boiling), fermentation, bleaching, or otherwise subjected to storage or treatment for later use.
  • Exemplary processing techniques are described, for example, in US Pat. Appl. Pub. Nos. 2009/0025739 to Brinkley et al. and 2011/0174323 to Coleman, III et al., which are incorporated by reference herein.
  • a harvested portion or portions of the plant of the Nicotiana species can be physically processed.
  • the tobacco material is used in a form that can be described as particulate (i.e., shredded, ground, granulated, or powder form).
  • the manner by which the tobacco material is provided in a finely divided or powder type of form may vary.
  • plant parts or pieces are comminuted, ground or pulverized into a particulate form using equipment and techniques for grinding, milling, or the like.
  • the plant material is relatively dry in form during grinding or milling, using equipment such as hammer mills, cutter heads, air control mills, or the like.
  • At least a portion of the tobacco material employed in the tobacco composition or product can have the form of an extract.
  • Tobacco extracts can be obtained by extracting tobacco using a solvent having an aqueous character such as distilled water or tap water.
  • aqueous tobacco extracts can be provided by extracting tobacco with water, such that water insoluble pulp material is separated from the aqueous solvent and the water soluble and dispersible tobacco components dissolved and dispersed therein.
  • Tobacco extraction techniques and tobacco extract processing techniques are described, for example, in US Pat. Pub. No. 2013/0312774 to Holton, Jr., which is incorporated by reference herein.
  • the pouched products of the invention can include a nicotinic compound.
  • nicotinic compound or “source of nicotine” often refers to naturally-occurring or synthetic nicotinic compound unbound from a plant material, meaning the compound is at least partially purified and not contained within a plant structure, such as a tobacco leaf. Most preferably, nicotine is naturally-occurring and obtained as an extract from a Nicotiana species (e.g., tobacco).
  • the nicotine can have the enantiomeric form S( ⁇ )-nicotine, R(+)-nicotine, or a mixture of S( ⁇ )-nicotine and R(+)-nicotine.
  • the nicotine is in the form of S( ⁇ )-nicotine (e.g., in a form that is virtually all S( ⁇ )-nicotine) or a racemic mixture composed primarily or predominantly of S( ⁇ )-nicotine (e.g., a mixture composed of about 95 weight parts S( ⁇ )-nicotine and about 5 weight parts R(+)-nicotine).
  • the nicotine is employed in virtually pure form or in an essentially pure form. Highly preferred nicotine that is employed has a purity of greater than about 95 percent, more preferably greater than about 98 percent, and most preferably greater than about 99 percent, on a weight basis.
  • Nicotinic compounds can include nicotine in free base form, salt form, as a complex, or as a solvate. See, for example, the discussion of nicotine in free base form in US Pat. Pub. No. 2004/0191322 to Hansson, which is incorporated herein by reference. At least a portion of the nicotinic compound can be employed in the form of a resin complex of nicotine, where nicotine is bound in an ion exchange resin, such as nicotine polacrilex. See, for example, U.S. Pat. No. 3,901,248 to Lichtneckert et al., which is incorporated herein by reference. At least a portion of the nicotine can be employed in the form of a salt.
  • Salts of nicotine can be provided using the types of ingredients and techniques set forth in U.S. Pat. No. 2,033,909 to Cox et al. and U.S. Pat. No. 4,830,028 to Lawson et al., and Perfetti, Beitrage Tabak Kauutz Int ., 12: 43-54 (1983), which are incorporated herein by reference. See, also, US Pub. No. 2011/0268809 to Brinkley et al., which is incorporated herein by reference. Additionally, salts of nicotine have been available from sources such as Pfaltz and Bauer, Inc. and K&K Laboratories, Division of ICN Biochemicals, Inc.
  • excipients or other additional ingredients that are particularly useful for the manufacture of nicotine-containing products or tobacco-containing products include fillers or carriers for active ingredients (e.g., calcium polycarbophil, microcrystalline cellulose, cornstarch, beet pulp fiber, silicon dioxide or calcium carbonate), thickeners, film formers and binders (e.g., hydroxypropyl cellulose, hydroxypropyl methylcellulose, acacia, sodium alginate, xanthan gum and gelatin), buffers and pH control agents (e.g., magnesium oxide, magnesium hydroxide, potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, or mixtures thereof), antiadherents (e.g., talc), glidants (e.g., colloidal silica), natural or artificial sweeteners (e.g., saccharin, acesulfame K, aspartame, sucralose, isomalt, lactose, mannitol, sorbitol,
  • Certain types of nicotine-containing products or tobacco-containing products also can have outer coatings composed of ingredients capable of providing acceptable outer coatings (e.g., an outer coating can be composed of ingredients such as carnauba wax, and pharmaceutically acceptable forms of shellacs, glazing compositions and surface polish agents). Adhesives, coatings, colorants, and other ingredients used in products described herein can be generally recognized as safe, non-toxic, ingestible and otherwise suitable for oral use.
  • compositions that are contained within the cavity defined by the water-permeable fabric pouch.
  • the composition thus can include a number of releasable components that are desired for release by the user into the user's mouth, such as flavor components and the like.
  • Some compositions can include releasable components that are desired to be partially, substantially completely, or completely prevented from release into the mouth under mouth conditions. In other words, although certain components may be released from a composition under mouth conditions, it may be desirable to modify the release of one or more of such components.
  • a pouched product also can comprise a release modifying agent.
  • a release modifying agent can be a material that is adapted to react with at least one of the releasable components in the composition that is positioned within the water-permeable fabric pouch and thereby modify the release thereof from the water-permeable fabric pouch.
  • a pouched product 200 is shown in FIG. 2 and can comprise a water-permeable fabric 220 in the form of a pouch which contains a composition 215 adapted for oral use.
  • the pouched product 200 further includes a release modifying agent 225 , which may be, for example, a particulate activated carbon or any further material as described herein.
  • a release modifying agent useful according to the present disclosure can be configured to modify the release of a releasable component in a variety of manners.
  • a release modifying agent can be adapted to bind with a releasable component in the composition.
  • the release modifying agent can be associated with the water-permeable fabric pouch in a manner such that the release modifying agent is not substantially disassociated from the pouched product under mouth conditions (i.e., there is substantially no release from the pouch into the mouth). Exemplary associations between the release modifying agent and the water-permeable fabric pouch are further described below.
  • the release modifying agent Since the release modifying agent is substantially prevented from disassociating from the water-permeable fabric pouch, a releasable component that is bound by the release modifying agent is likewise substantially prevented from movement out of the water-permeable fabric pouch. By such binding, the release modifying agent prevents the release of at least a portion of the releasable component (i.e., the bound component) from the water-permeable fabric pouch.
  • a release modifying agent that is a binding agent may be configured to bind any percentage of the releasable component that may be released from the mass of the composition contained within the water-permeable fabric pouch up to 100% by weight of the releasable component.
  • a release modifying binding agent may be configured to bind about 1% to about 99.9%, about 10% to about 99.5%, or about 25% to about 99% by weight of the releasable component that is released from the composition under mouth conditions.
  • the release modifying binding agent thus may be included in the pouched product in a mass sufficient to achieve the desired binding.
  • the binding achieved with a release modifying binding agent can be by one or more mechanisms.
  • the release modifying binding agent may be configured to physically bind the releasable component; the release modifying binding agent may be configured to covalently bond with the releasable component; the release modifying agent may be configured to ionically bond with the releasable component; the release modifying agent may be configured to undergo a further bond (e.g., hydrogen bonds and Van der Waals forces) with the releasable component.
  • a release modifying agent can be adapted to chemically or physically modify a releasable component in the composition prior to or during release thereof from the water-permeable fabric pouch.
  • the releasable component thus may be altered so that the material that ultimately does move through the water-permeable fabric pouch is in some way different from the releasable component that is initially released from the composition.
  • the release modifying agent may be an oxidizing agent or a reducing agent that oxidizes or reduces a releasable component so that at least a portion of the releasable component that is released into the mouth is in an oxidized form or a reduced form relative to the releasable component that is initially released from the composition within the water-permeable fabric pouch.
  • a release modifying agent may be configured as a decomposing agent and may at least partially decompose a releasable component.
  • a release modifying agent may be configured as a bond cleaving agent that facilitates scission of a releasable component.
  • a release modifying agent may be configured as a derivatizing agent that reacts with the releasable component for form a derivative of the releasable component.
  • a combination of release modifying agents may be used so that the release of multiple releasable components may be modified.
  • a plurality of release modifying agents may separately modify the release of different releasable components (e.g., release modifying agent A modifying the release of releasable component X and release modifying agent B modifying the release of releasable component Y).
  • release modifying agent A modifying the release of releasable component X
  • release modifying agent B modifying the release of releasable component Y.
  • a plurality of binding agents can be used to bind, and thus modify the release of, a plurality of releasable components.
  • a plurality of release modifying agents may be used in combination to modify the release of the same releasable component.
  • a first release modifying agent may be adapted to chemically or physically modify a releasable component
  • a second release modifying agent may be adapted to bind one or more materials representing the modifying releasable component (e.g., release modifying agent A′ changing a releasable component X′ into modified releasable components Z′ and Z′′, one or both of which may be bound by release modifying agent B′).
  • a release modifying agent may be incorporated into the pouched product in a variety of manners.
  • a release modifying agent can form at least a part of the water-permeable fabric.
  • the water-permeable fabric may be formed of a plurality of fibers, and the release modifying agent can be attached (e.g., covalently, ionically, or the like) to at least a portion of the fibers.
  • at least a portion of the fibers may be formed from a material that is a release modifying agent (e.g., a polymeric material).
  • the water-permeable fabric pouch can be infused with the release modifying agent.
  • the release modifying agent can be adsorbed or absorbed by at least a portion of the water-permeable fabric pouch.
  • a release modifying agent can be in a powdered or particulate form.
  • the particulate release modifying agent may be adhered or otherwise attached to the water-permeable fabric.
  • the release modifying agent 225 may be a layer of particulate activated carbon adhered to the water permeable fabric 220 .
  • the particulate release modifying agent may be associated with the composition contained in the cavity of the water-permeable fabric pouch.
  • the particulate release modifying agent 325 may be admixed with the composition 315 within the water permeable fabric 320 .
  • the water-permeable fabric may exhibit a porosity sufficiently sized to allow the releasable components to move therethrough under mouth conditions.
  • a particulate release modifying agent is sized so that the particles are substantially prevented from passing through the fabric.
  • particles of a release modifying agent may be provided in a separate pouch that can be included inside the water-permeable pouch.
  • the particulate release modifying agent 425 may be contained in a containment fleece 430 and positioned within the water permeable fabric 420 along with the composition 415 within.
  • a release modifying agent can be in an encapsulated form.
  • the capsule can comprise a capsule wall that is formed of a material that is configured to allow for dispersement of the release modifying agent under desired conditions.
  • the capsule wall may comprise a material that is configured to dissolve or otherwise degrade under mouth conditions.
  • the capsule is configured to disperse the release modifying agent sufficiently rapidly so as to modify the release of the releasable component from the composition in the water-permeable fabric pouch.
  • the capsule wall may comprise a material that is configured to be broken or otherwise degraded by shear forces (e.g., chewing). While suitable encapsulated materials may be described herein in relation to microcapsules, it is understood that such terminology is not intended to be viewed as limiting of the capsule sizes.
  • suitable microcapsules can be sufficient to allow for normal handling and storage without significant degree of premature or undesirable breakage.
  • Providing capsules that possess both suitable integrity during storage and the ability to rupture or otherwise break down at the time of use can be determined by experimentation, depending upon factors such as capsule size and type, and is a matter of design choice. See, for example, U.S. Pat. Pub, No. 2007/0068540 to Thomas et al., which is incorporated herein by reference.
  • An exemplary capsule may include an outer shell incorporating a material such as wax, gelatin, cyclodextrin, or alginate, and an inner payload incorporating the release modifying agent, which may be particulate in some embodiments or may be an aqueous or non-aqueous liquid (e.g., a solution or dispersion of at least one release modifying agent within water or an organic liquid such as an alcohol or oil; or a mixture of water and a miscible liquid like alcohol or glycerin).
  • a plurality of such capsules may be incorporated within the pouch along with the composition to be retained therein; and during use of the product, a crushing or other destruction of the capsules may allow the capsules to release the additive contained therein.
  • the capsules used in the pouched product of the invention may be uniform or varied in size, weight, and shape.
  • a representative capsule can be generally spherical in shape.
  • suitable capsules may have other types of shapes, such as generally rectilinear, oblong, elliptical, or oval shapes.
  • Exemplary microcapsules may have diameters of less than about 100 microns, such as microcapsules having diameters in the range of about 1 to about 40 microns, or about 1 micron to about 20 microns.
  • larger capsules may be utilized.
  • a capsule utilized in the pouch product may have a size of about 0.5 mm to about 5 mm or about 0.6 mm to about 3 mm in diameter.
  • the number of capsules incorporated into the pouched product can vary, depending upon factors such as the size of the capsules, the character or nature of the additive in the payload, the desired attributes of the composition within the pouch and the desired release modification thereof, and the like.
  • only a single capsule may be included.
  • a capsule 540 having the release modifying agent (not visible) provided therein may be positioned within the water permeable fabric 520 along with the composition 515 within.
  • the single capsule 540 can thus be relatively large in size.
  • a plurality of capsules may be included.
  • a plurality of capsules 540 ′ each having the same or a different release modifying agent (not visible) provided therein may be positioned within the water permeable fabric 520 ′ along with the composition 515 ′ within.
  • the plurality of capsules 540 ′ can thus be relatively small in size.
  • microcapsules may be used.
  • the number of capsules incorporated within pouched product for example, can exceed about 5, can exceed about 10, can exceed about 20, can exceed about 40, and can even exceed about 100. In certain embodiments, the number of capsules/microcapsules can be greater than about 500, and even greater than about 1,000.
  • the total weight of the capsules contained within the smokeless tobacco product may vary, but is typically greater than about 10 mg, often greater than about 20 mg, and can be greater than about 30 mg.
  • the total weight of the capsules is typically less than about 200 mg, often less than about 100 mg, and can be less than about 50 mg.
  • the capsules can be formed using any encapsulating technology known in the art.
  • microcapsules can be formed using any of various chemical encapsulation techniques such as solvent evaporation, solvent extraction, organic phase separation, interfacial polymerization, simple and complex coacervation, in-situ polymerization, liposome encapsulation, and nanoencapsulation.
  • physical methods of encapsulation could be used, such as spray coating, pan coating, fluid bed coating, annular jet coating, spinning disk atomization, spray cooling, spray drying, spray chilling, stationary nozzle coextrusion, centrifugal head coextrusion, or submerged nozzle coextrusion.
  • the outer wall or shell material and solvents used to form the capsules can vary.
  • Classes of materials that are typically used as wall or shell materials include proteins, polysaccharides, starches, waxes, fats, natural and synthetic polymers, and resins.
  • Exemplary materials for use in the microencapsulation process used to form the microcapsules include gelatin, acacia (gum arabic), polyvinyl acetate, potassium alginate, carob bean gum, potassium citrate, carrageenan, potassium polymetaphosphate, citric acid, potassium tripolyphosphate, dextrin, polyvinyl alcohol, povidone, dimethylpolysiloxane, dimethyl silicone, refined paraffin wax, ethylcellulose, bleached shellac, modified food starch, sodium alginate, guar gum, sodium carboxymethylcellulose, hydroxypropyl cellulose, sodium citrate, hydroxypropylmethylcellulose, sodium ferrocyanide, sodium polyphosphates, locust bean gum, methylcellulose, sodium trimetaphosphate, methyl ethyl cellulose, sodium tripolyphosphate, microcrystalline wax, tannic acid, petroleum wax, terpene resin, tragacanth, polyethylene, xanthan gum, and polyethylene glycol
  • Microcapsules are commercially available, and exemplary types of microcapsule technologies are of the type set forth in Gutcho, Microcapsules and Microencapsulation Techniques (1976); Gutcho, Microcapsules and Other Capsules Advances Since 1975 (1979); Kondo, Microcapsule Processing and Technology (1979); Iwamoto et al., AAPS Pharm. Sci. Tech. 2002 3(3): article 25; U.S. Pat. No. 3,550,598 to McGlumphy; U.S. Pat. No. 4,889,144 to Tateno et al.; U.S. Pat. No. 5,004,595 to Cherukuri et al.; U.S. Pat. No. 5,690,990 to Bonner; U.S. Pat. No.
  • microcapsules are available from sources such as Microtek Laboratories of Dayton, Ohio.
  • Exemplary types of commercially available microencapsulating techniques include those marketed under the trade names ULTRASEALTM and PERMASEALTM available from Givaudan headquartered in Vernier, Switzerland.
  • Representative types of capsules are of the type commercially available as “Momints” by Yosha! Enterprises, Inc. and “Ice Breakers Liquid Ice” from The Hershey Company. Representative types of capsules also have been incorporated in chewing gum, such as the type of gum marketed under the tradename “Cinnaburst” by Cadbury Adams USA. Representative types of capsules and components thereof also are set forth in U.S. Pat. No. 3,339,558 to Waterbury; U.S. Pat. No. 3,390,686 to Irby, Jr. et al.; U.S. Pat. No. 3,685,521 to Dock; U.S. Pat. No. 3,916,914 to Brooks et al.; U.S. Pat.
  • the capsules may be colored, provided with smooth or rough surfaces, have rigid or pliant shells, have brittle or durable shells, or other desired features or characters.
  • any material that will react with a releasable component as defined herein may be used as a release modifying agent.
  • the release modifying agent is formed of a material that is considered safe for oral use in humans and/or safe for ingestion by humans.
  • a release modifying agent may be defined in relation to its reactivity with certain elements, molecules, compounds, or the like that may be present in, and releasable from, the composition included in the pouched product. Such reactivity may relate to binding (e.g., absorption, adsorption, covalent bonding) or a specific chemical reaction.
  • a release modifying agent may be any material that is adapted to react with one or more of the following: acetaldehyde, arsenic, benzo[a]pyrene (BaP), cadmium, crotonaldehyde, formaldehyde, nicotine, nicotine-derived nitrosamine ketone (NNK), N-nitrosonornicotine (NNN), other tobacco-specific nitrosamines, derivatives thereof, decomposition products thereof, precursors thereof, and the like.
  • a release modifying agent further may be any material that is adapted to react with a compound that is releasable from tobacco under mouth conditions.
  • a release modifying agent also may be any material that is adapted to react with compounds that may be disadvantageously present in a portion of the tobacco seed, e.g., in tobacco seed oil, such as pesticides (e.g., herbicides, insecticides, or rodenticides), fertilizers, or residues thereof.
  • pesticides e.g., herbicides, insecticides, or rodenticides
  • Exemplary pesticides that can be targeted for release modification include, but are not limited to, ethion, parathion, diazinon, methyl parathion, thiodan, bromopropylate, pirimiphos methyl, fenthion, prochloraz, pyridapenthion, malathion, chlorpyriphos, and imazalil.
  • the release modifying agent may be characterized based upon one or more of its reactivity, it composition, its physical structure, and the like.
  • a release modifying agent may include any of the following: adsorbents, absorbents, molecularly imprinted polymers (MIPS), non-molecularly imprinted polymers (NIPS), botanicals, antioxidants, chelating agents, cyclodextrins, and combinations thereof.
  • Absorbents can include any material subject to wetting and adapted to draw a releasable component into the structure thereof.
  • Absorbents may particularly be porous articles, including fibrous materials, and may be specifically adapted to wicking of a liquid (e.g., saliva including a releasable component) into the structure thereof.
  • a liquid e.g., saliva including a releasable component
  • Adsorbents can include any material adapted for adhering a releasable component on a surface thereof (i.e., undergoing surface adsorption). Suitable adsorbents may exhibit physical adsorption and/or chemical adsorption. Non-limiting examples of adsorbents that may be suitable for use as a release modifying agent include activated carbon, activated aluminas, molecular sieves (including carbon molecular sieves and zeolites—e.g., aluminosilicates), clays, silica gels, ion exchange resins, and sodium bicarbonate.
  • Activated carbon can be particularly useful and preferably consists primarily of carbon—e.g., having a carbon content above about 80 weight percent, and more preferably above about 90 weight percent.
  • Preferred carbonaceous materials are provided by carbonizing or pyrolyzing bituminous coal, tobacco material, softwood pulp, hardwood pulp, coconut shells, almond shells, grape seeds, walnut shells, macadamia shells, kapok fibers, cotton fibers, cotton linters, and the like. Carbon from almond shells, grape seeds, walnut shells, and macadamia nut shells are believed to provide greater vapor phase removal of certain compounds as compared to coconut shell carbon. Examples of suitable carbonaceous materials are activated coconut hull based carbons available from Calgon Corp.
  • a molecularly imprinted polymer is a polymeric material that exhibits high binding capacity and selectivity for a specific target molecule or class of target molecules.
  • MIPs comprise cavities that are engineered to selectively bind one or more target molecules. Unlike most separation particles that exhibit only non-selective interactions, MIPs have a selective recognition site, which is sterically and/or chemically complementary to a particular target molecule or class of structurally related target molecules.
  • General discussion of MIPs is provided, for example, in Cormack et al., J. Chrom. B. 804:173-182 (2004); U.S. Pat. No. 5,630,978 to Domb; and US Pat. Appl. Pub. Nos.
  • MIPs are typically prepared by copolymerizing functional monomers and crosslinkers in the presence of a “template” molecule that provides a three-dimensional outline around which the polymer is formed.
  • the functional monomers organize around the template molecule and are then locked into position by polymerization with the crosslinkers and other functional monomers.
  • the template molecule can be the target molecule or a structural analogue which mimics the target molecule.
  • the template molecule directs the organization of the functional groups on the monomer units, and, following preparation of the polymer, the template molecule is removed from the MIP, providing cavities that are designed for the specific binding of a target compound.
  • Any method of polymer synthesis can be used to produce MIPs and NIPs.
  • cationic or anionic polymerization may be used.
  • Free radical polymerization is the most commonly used method for the preparation of MIPs and NIPs.
  • the preparation by free radical polymerization typically requires one or more monomers, one or more crosslinkers, one or more initiators, and, optionally, one or more solvents, in addition to the template molecule. Examples of monomers, crosslinkers, initiators, solvents, template molecules, and methods of preparation useful in forming MIPs and NIPs are described in U.S. Pat. No. 7,985,818 to Pertsovich and U.S. Pat. Pub. No.
  • a MIP and/or a NIP may form at least a portion of the water-permeable fabric used to form the pouch, such as by utilizing fibers formed from the MIP and/or the NIP or by attaching the MIP and/or NIP to the fibers.
  • Botanical materials refer to any plant material, including plant material in its natural form and plant material derived from natural plant materials, such as extracts or isolates form plant materials or treated plant materials (e.g., plant materials subjected to heat treatment, fermentation, or other treatment processes capable of altering the chemical nature of the material).
  • botanicals include but are not limited to “herbal materials,” which refer to seed-producing plants that do not develop persistent woody tissue and are often valued for their medicinal or sensory characteristics (e.g., teas or tisanes).
  • Reference to botanical material is not intended to include tobacco materials (i.e., does not include any Nicotiana species).
  • the botanical materials may comprise, without limitation, any of the compounds and sources set forth herein, including mixtures thereof. Certain botanical materials of this type are sometimes referred to as dietary supplements, nutraceuticals, “phytochemicals” or “functional foods.”
  • Suitable botanicals particularly may exhibit antioxidant characteristics, and such botanicals may be particularly preferred, as well as non-botanical materials that exhibit antioxidant characteristics.
  • Exemplary botanical materials many of which are associated with antioxidant characteristics, include without limitation acai berry, alfalfa, allspice, annatto seed, apricot oil, basil, bee balm, wild bergamot, black pepper, blueberries, borage seed oil, bugleweed, cacao, calamus root, catnip, catuaba, cayenne pepper, chaga mushroom, chervil, cinnamon, dark chocolate, potato peel, grape seed, ginseng, gingko biloba , Saint John's Wort, saw palmetto, green tea, black tea, black cohosh, cayenne, chamomile, cloves, cocoa powder, cranberry, dandelion, grapefruit, honeybush, echinacea , garlic, evening primrose, feverfew, ginger, goldenseal, hawthorn, hibiscu
  • Botanical materials often include compounds from various classes known to provide certain bioactive effects, such as minerals, vitamins such a ascorbic acid, isoflavones, phytoesterols, allyl sulfides, dithiolthiones, isothiocyanates, indoles, lignans, flavonoids, polyphenols, plant phenolics, tocopherols, ubiquinone, benzodioxoles, carotenoids, etc.
  • minerals such ascorbic acid, isoflavones, phytoesterols, allyl sulfides, dithiolthiones, isothiocyanates, indoles, lignans, flavonoids, polyphenols, plant phenolics, tocopherols, ubiquinone, benzodioxoles, carotenoids, etc.
  • Antioxidants obtained from botanicals can be classified in the following groups: monoterpenoid phenols; alcohols such as thymol, carvacol, menthol; p-cymene; diterpene phenols such as carnosic acid, carnosol, rosmanol; hydroxycinnamic type compounds such as caffeic acid, chlorogenic acid, rosmarinic acid, p-coumaric acid, resveratrol, curcumin, eugenol, cinnamaladehyde; hydroxybenzoic acids and derivatives such as gallic acid, protocatechuic acid, propyl gallate; 2-benzopryrones such as scopoletin, coumarin; 4-benzopyrones such as quercetin, genistein, naringenin, diosmin, rutin; dihydrochalcones such as aspalathin, notophagin; flavanols such as epicatechin, epigallocatechin, epicate
  • Exemplary compounds found in botanical materials include, but are not limited to, propylene glycol, lactic acid, glycolic acid, alanine, camphor, pyruvic acid, aspalathin, borneol, menthol, phosphate, glycerin, proline, succinic acid, thymol, glyceric acid, 2-butenedioic acid, 3-hydroxyglutaric acid, malic acid, 5-oxoproline (pyroglutamic acid), aspartic acid, trihydroxybutanoic acid, glutamine, asparagine, levoglucosan, xylitol, ribitol, 2-keto-L-gluconic acid, fructose, caffeine, citric acid, glucosamine, neophytadiene, altrose, quinic acid, xylulose, glucose, inositol, 2-amino-2-deoxyglucose, glucitol, ascorbic acid, glucose, gallic acid, glu
  • the botanical material can be used in the present pouched products in a variety of forms.
  • Exemplary forms include plant materials in shredded or particulate (e.g., a milled or ground product in a form characterized as granular or powder) form.
  • Exemplary forms also include isolated components of plant materials in forms such as oils, aqueous extracts, or alcohol (e.g., ethanol) extracts, which can be optionally used in solid form (e.g., freeze-dried or spray-dried form). Oils, aqueous extracts, and the like may be infused into the water-permeable fabric and/or may be encapsulated, in non-limiting embodiments.
  • Botanicals, including botanically derived antioxidants, that may be useful according to the present disclosure are further described in U.S. patent application Ser. No. 14/072,318, filed Nov. 5, 2013, the disclosure of which is incorporated herein by reference.
  • a chelating agent is understood to be a ligand that is adapted for forming a chelate complex with a substrate. Chelating agents may be particularly useful as a release modifying agent for metal species.
  • Non-limiting examples of chelating agents include dimercaprol or British anti-Lewisite (BAL); succimer or dimercaptosuccinic acid (DMSA); unithiol or 2,3-Dimercapto-1-propanesulfonic acid (DMPS); D-penicillamine (DPA); N-acetyl-D-penicillamine (NAPA); calcium disodium ethylenediaminetetraacetate (CaNa(2)EDTA); calcium trisodium or zinc trisodium diethylenetriaminepentaacetate (CaNa(3)DTPA, ZnNa(3)DTPA); deferoxamine (DFO); deferiprone; triethylenetetraamine or trientine; N-acetylcysteine (NAC); Prussian Blue (
  • Cyclodextrins are understood to be cyclic oligosaccharides composed of a number (e.g., 5 or greater) of ⁇ -D-glucopyranoside units. Non-limiting examples include ⁇ -cyclodextrin (6 units), ⁇ -cyclodextrin (7 units), and ⁇ -cyclodextrin (8 units). Cyclodextrins can provide a hydrophilic interior with a hydrophobic exterior thus making the materials useful for forming a variety of complexes.
  • a water-permeable fabric pouch as described herein can be characterized as comprising a filter media.
  • a filter media can include any material that, under the specified conditions of use, is permeable to one or more components of a mixture, solution, or suspension, and is impermeable to the remaining components.
  • the nonwoven web forming the water-permeable fabric may be formed so as to be a filter media by nature of the porosity thereof, the fibers used in forming the web, and/or additives to the web (e.g., filter materials added to the web during formation thereof).
  • a release modifying agent in particulate form may be included in the pouched product such that, under mouth conditions, the particulates substantially coat, or at least partially coat, the interior of the water-permeable fabric such that releasable components combined with saliva being withdrawn from the pouch may be modified in one or more release characteristics through reaction with the release modifying agent.
  • the water-permeable fabric may be infused with a composition (e.g., a botanical or other antioxidant) so that, under mouth conditions, the infused material functions to modify the release of releasable components that may otherwise pass through the water-permeable fabric.
  • the water-permeable fabric may substantially function to filter one or more releasable components—i.e., such that the one or more releasable components is not permeable to the water-permeable fabric while other materials (e.g., saliva and optionally some releasable components from the composition) are permeable to the water-permeable fabric.
  • first, second, and third releasable components may be released from the composition within the cavity of the water-permeable fabric pouch, such as by forming a solution with saliva, and while the saliva, the first releasable component, and the second releasable component may be permeable to the water-permeable fabric, the third releasable component may be non-permeable to the water-permeable fabric because of the presence of the release modifying agent and/or the nature of the water-permeable fabric otherwise as a filter media.
  • a water-permeable fabric useful according to the present disclosure may be formed of any material that provides the requisite water permeability so that releasable components may be released into the mouth and that still exhibits sufficient structure to retain the solid composition (e.g., power, particles, shredded material, or the like) inside the cavity defined by the fabric.
  • the fabric particularly may be formed of fibers and more particularly may be formed of a nonwoven web of fibers.
  • fiber is defined as a basic element of textiles. Fibers are often in the form of a rope- or string-like element.
  • the term “fiber” is intended to include fibers, filaments, continuous filaments, staple fibers, and the like.
  • multicomponent fibers refers to fibers that comprise two or more components that are different by physical or chemical nature, including bicomponent fibers. Specifically, the term “multicomponent fibers” includes staple and continuous fibers prepared from two or more polymers present in discrete structured domains in the fiber, as opposed to blends where the domains tend to be dispersed, random or unstructured.
  • nonwoven is used herein in reference to fibrous materials, webs, mats, bans, or sheets in which fibers are aligned in an undefined or random orientation.
  • the nonwoven fibers are initially presented as unbound fibers or filaments.
  • fibers or filaments may be bound together.
  • the manner in which the fibers or filaments are bound can vary, and include thermal, mechanical and chemical techniques that are selected in part based on the desired characteristics of the final product.
  • a heat sealable binder coating may be utilized on the water-permeable fabric. In other embodiments, such coating may expressly be absent or reduced. Accordingly, in certain embodiments of the invention, the pouched product can be described as substantially free of a heat sealable binder coating.
  • the nonwoven web used to form the pouched product can comprise no more than about 0.5% by weight, no more than about 0.25% by weight, or no more than about 0.1% by weight (based on total weight of the nonwoven web) of a heat sealable binder coating. In some embodiments, the nonwoven web will be completely free of heat sealable binder coatings.
  • heat sealable binder coatings refers to liquid coating materials, such as acrylic polymer compositions, applied to a nonwoven web and which are capable of sealing seams of individual pouches upon heating.
  • a fibrous nonwoven web useful in forming the water-permeable fabric can include a plurality of heat sealing binder fibers comprising a thermoplastic polymer capable of providing the function of heat sealing of the pouch.
  • a “binder fiber” can be a fiber of any type, size, chemistry, etc. that can be used for the purpose of undergoing softening or melting upon heating, such that the binder fiber can act as a binding agent for the nonwoven web.
  • Nonwoven webs including heat sealing binder fibers are described in U.S. application Ser. No. 14/484,956, filed Sep. 12, 2014, the disclosure of which is incorporated herein by reference in its entirety.
  • a variety of fibers can be used to form a nonwoven “fleece” pouch—i.e., a water-permeable fabric.
  • a nonwoven “fleece” pouch i.e., a water-permeable fabric.
  • cellulosic fibers e.g., regenerated cellulose known as rayon or viscose fibers
  • the fibers can be staple fibers.
  • Each fiber in the nonwoven web can be a homocomponent fiber; however bicomponent fibers may be used in forming the nonwoven web.
  • the water-permeable fabric can be formed of a single fiber type or may be formed of a plurality of fiber types.
  • non-limiting examples of the types of fibers that can be used in forming the nonwoven web include those made of wool, cotton, fibers made of cellulosic material, such as regenerated cellulose, cellulose acetate, cellulose triacetate, cellulose nitrate, ethyl cellulose, cellulose acetate propionate, cellulose acetate butyrate, hydroxypropyl cellulose, methyl hydroxypropyl cellulose, protein fibers, and the like. See also, the fiber types set forth in US Pat. Appl. Pub. Nos. 2014/0083438 to Sebastian et al. and 2014/0026912 to Rushforth et al., which are incorporated herein by reference.
  • Regenerated cellulose fibers are particularly advantageous, and are typically prepared by extracting non-cellulosic compounds from wood, contacting the extracted wood with caustic soda, followed by carbon disulfide and then by sodium hydroxide, giving a viscous solution. The solution is subsequently forced through spinneret heads to create viscous threads of regenerated fibers.
  • Exemplary methods for the preparation of regenerated cellulose are provided in U.S. Pat. No. 4,237,274 to Leoni et al; U.S. Pat. No. 4,268,666 to Baldini et al; U.S. Pat. No. 4,252,766 to Baldini et al.; U.S. Pat. No.
  • the fibers used in the nonwoven web can vary and include fibers having any type of cross-section, including, but not limited to, circular, rectangular, square, oval, triangular, and multilobal.
  • the fibers can have one or more void spaces, wherein the void spaces can have, for example, circular, rectangular, square, oval, triangular, or multilobal cross-sections.
  • the fibers can be selected from single-component (i.e., uniform in composition throughout the fiber) or multicomponent fiber types including, but not limited to, fibers having a sheath/core structure and fibers having an islands-in-the-sea structure, as well as fibers having a side-by-side, segmented pie, segmented cross, segmented ribbon, or tipped multilobal cross-sections.
  • the physical parameters of fibers useful in forming a nonwoven web can vary.
  • the fibers used in the nonwoven web can have varying size (e.g., length, dpf) and crimp characteristics.
  • fibers used in the nonwoven web can be nano fibers, sub-micron fibers, and/or micron-sized fibers.
  • fibers useful herein can measure about 1.5 dpf to about 2.0 dpf, or about 1.6 dpf to about 1.90 dpf.
  • each fiber can be a staple fiber.
  • Each fiber length can measure about 35 mm to about 60 mm, or about 38 mm to about 55 mm, for example.
  • each fiber can measure about 4-10 crimps per cm, or about 5-8 crimps per cm. It is advantageous for all fibers in the nonwoven web to have similar fiber size and crimp attributes to ensure favorable blending and orientation of the fibers in the nonwoven web.
  • the means of producing the nonwoven web can vary.
  • Web formation can be accomplished by any means known in the art.
  • Web formation will typically involve a carding step, which involves deposition of the fibers (e.g., the heat sealable binder fibers and any additional fibers) onto a surface followed by aligning/blending the fibers in a machine direction. Thereafter, the nonwoven web is typically subjected to some type of bonding/entanglement including, but not limited to, thermal fusion or bonding, mechanical entanglement, chemical adhesive, or a combination thereof.
  • the nonwoven web is bonded thermally using a calendar (which can provide flat or point bonding), steam jet bonding, or a thru-air oven. Additional bonding methods include ultrasonic bonding and crimping.
  • needle punching is utilized, wherein needles are used to provide physical entanglement between fibers.
  • the web is entangled using hydroentanglement, which is a process used to entangle and bond fibers using hydrodynamic forces.
  • the nonwoven web is made by a fleece carding process with point bonding.
  • the point bonding (e.g., using a calendar) should be limited to a relatively small portion of the surface area of the nonwoven web to maintain good porosity in the web for migration of water-soluble components through the web during oral use.
  • the point bonding is limited to less than about 60% of the surface area of the nonwoven web (or resulting pouch), such as less than about 50%, less than about 30%, or less than about 20% (e.g., about 1% to about 50%, about 5% to about 40%, or about 10% to about 30%).
  • An advantage of point bonding is the ability to control the porosity, flexibility and fabric strength.
  • the nonwoven web can be subjected to hydroentangling.
  • hydroentangled or “spunlaced” as applied to a nonwoven fabric herein defines a web subjected to impingement by a curtain of high speed, fine water jets, typically emanating from a nozzle jet strip accommodated in a pressure vessel often referred to as a manifold or an injector.
  • This hydroentangled fabric can be characterized by reoriented, twisted, turned and entangled fibers.
  • the fibers can be hydroentangled by exposing the nonwoven web to water pressure from one or more hydroentangling manifolds at a water pressure in the range of about 10 bar to about 1000 bar.
  • spunlace technology in certain embodiments, will have less impact on porosity of the web and, thus, may enhance flavor transfer through the nonwoven pouch material.
  • the nonwoven web can be subjected to a second bonding method in order to reduce elongation of the web during processing.
  • carded and hydroentangled nonwoven webs of the invention can exhibit significant elongation during high speed processing on pouching equipment. Too much elongation of the nonwoven web can cause the web to shrink during processing, such that the final product is not sized appropriately. As such, it can be necessary to modify process equipment to fit a wider roll of fleece, for example, to compensate for any shrinkage in the final product due to elongation.
  • the nonwoven web can be point bonded after the first bonding (e.g., hydroentangling) is completed.
  • a second bonding process can increase the tensile strength of the nonwoven web and reduce elongation characteristics.
  • a point bonding process can bond a nonwoven web by partially or completely melting the web (e.g., the heat sealable binder fibers) at discrete points.
  • the nonwoven web can be subjected to ultrasonic bonding after initial bonding of the web. Any ultrasonic bonding system for nonwoven materials known in the art can be used to ultrasonically bond the nonwoven web.
  • the nonwoven web can be subjected to point bonding via embossed and/or engraved calendar rolls, which are typically heated. See, e.g., the point bonding methods incorporating the use of very high calendar pressures and embossing techniques discussed in U.S. Pat. Publ. No. 2008/0249492 to Schmidt, herein incorporated by reference in its entirety.
  • the point bonding process is typically limited to less than about 60% of the surface area of the nonwoven web as noted above.
  • product identifying information may be included on the water-permeable fabric pouch.
  • the product identifying information is selected from the group consisting of product brand, a company name, a corporate logo, a corporate brand, a marketing message, product strength, active ingredient, product manufacture date, product expiration date, product flavor, product release profile, weight, product code (e.g., batch code), other product differentiating markings, and combinations thereof.
  • the processing techniques used to blend, entangle and bond the nonwoven web can also impart a desired texture to the fibrous nonwoven web material. For instance, point bonding or hydroentangling can impart a desired texture (e.g. a desired pattern) to the nonwoven web. This textured pattern can include product identifying information.
  • Product identifying information may be included in further manners, such as described in U.S. Pub. No. US 2014/0255452 to Reddick et al., the disclosure of which is incorporated herein by reference.
  • the fibrous webs can have varying thicknesses, porosities and other parameters.
  • the nonwoven web can be formed such that the fiber orientation and porosity of the pouched product formed therefrom can retain the composition adapted for oral use that is enclosed within the outer water-permeable pouch, but can also allow the flavors of the composition to be enjoyed by the consumer.
  • the fibrous webs can have a basis weight of about 20 gsm to about 35 gsm, or about 25 gsm to about 30 gsm. In a preferred embodiment, the fibrous web can have a basis weight of about 28 gsm.
  • Basis weight of a fabric can be measured using ASTM D3776/D3776M-09a (2013) (Standard Test Methods for Mass Per Unit Area (Weight) of Fabric), for example.
  • the fibrous web can have a thickness of about 0.1 mm to about 0.15 mm (e.g., about 0.11 mm)
  • the fibrous web can have an elongation of about 70% to about 80%, e.g., about 78%.
  • the fibrous web can have a peak load of about 4 lbs. to about 8 lbs., e.g., about 5.5 lbs.
  • Elongation and breaking strength of textile fabrics can be measured using ASTM D5034-09(2013) (Standard Test Method for Breaking Strength and Elongation of Textile Fabrics (Grab Test)), for example.
  • the fibrous web can have a Tensile Energy Absorption (TEA) of about 35 to about 40, e.g., about 37.
  • the fibrous web can have a porosity of greater than about 10,000 ml/min/cm 2 .
  • TEA can be measured, for example, as the work done to break the specimen under tensile loading per lateral area of the specimen.
  • Porosity, or air permeability of textile fabrics can be measured using ASTM D737-04(2012) (Standard Test method for Air Permeability of Textile Fabrics), for example.
  • the water-permeable fabric can be made from a nonwoven web that is substantially a single layer web or fabric.
  • the water permeable fabric can be a multilayer composite made up of two or more nonwoven layers. Each nonwoven layer can be formed by processes discussed above. Multilayer structures that may be used according to the present disclosure are described in U.S. application Ser. No. 14/484,956, filed Sep. 12, 2014, which is incorporated herein by reference.
  • a multilayer web can comprise a hydrophilic layer and a hydrophobic layer (compared to each other). The outer layer specifically may be hydrophilic, and the inner layer specifically may be hydrophobic.
  • the hydrophobic layer can, during storage of the pouched product, retain any moisture in the composition adapted for oral use such that flavors in the composition are not lost due to moisture loss.
  • capillaries in the hydrophobic layer can wick out moisture into the mouth of the user, such that flavors are released into the oral cavity when used.
  • the pouch material can enhance storage stability without significantly compromising the enjoyment of the product by the end user.
  • the two layers can be formed into a multi-layer composite nonwoven material using any means known in the art, such as by attaching the two layers together using adhesive or stitching.
  • the hydrophobicity of a textile material can be evaluated, for example, by measuring the contact angles between a drop of liquid and the surface of a textile material, as is known in the art.
  • the hydrophilic and hydrophobic layers can be formed from similar nonwoven web compositions (e.g., both are constructed of a blend of viscose fibers with heat sealable binders fiber such as PLA fibers), but wherein one of the nonwoven webs is treated to enhance either hydrophobicity or hydrophilicity.
  • a layer of the nonwoven web can be treated with a wet chemical solution to confer hydrophilicity thereupon.
  • a nonwoven web layer is treated with an aqueous alcohol solution containing a food-grade surfactant.
  • the surfactant may include, for example one or more of sorbitan aliphatic acid ester, polyglycerin aliphatic acid ester, or sucrose aliphatic acid ester (see, e.g., U.S. Pat. No. 7,498,281 to Iwasaki et al., which is incorporated herein by reference).
  • the fleece fabric layers can be made hydrophilic or hydrophobic by changing the cellulose fiber chosen. For example, predominantly hydrophobic cellulose fibers are commercially available as Tencel® Biosoft from Leming of Austria and as Olea Fiber from Kelheim of Germany.
  • the hydrophilic layer can incorporate cationic or anionic cellulose fibers that are also available from Kelheim of Germany, for example.
  • the hydrophilic layer can contain additives such as polyethylene glycols, methyl cellulose, hydroxypropylmethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose phthalate, polyvinyl pyrrolidone, polyvinyl alcohol, polyacrylic acids, gelatins, alginates, sulfosuccinates, and combinations thereof. Any of the exemplified fibers may be used in forming a single layer water-permeable fabric in some embodiments.
  • Various manufacturing apparatuses and methods can be used to create a pouched product described herein.
  • US Publication No. 2012/0055493 to Novak, III et al. previously incorporated by reference, relates to an apparatus and process for providing pouch material formed into a tube for use in the manufacture of smokeless tobacco products.
  • Similar apparatuses that incorporate equipment for supplying a continuous supply of a pouch material e.g., a pouch processing unit adapted to supply a pouch material to a continuous tube forming unit for forming a continuous tubular member from the pouch material
  • Representative equipment for forming such a continuous tube of pouch material is disclosed, for example, in U.S. Patent Application Publication No.
  • the apparatus further includes equipment for supplying pouched material to the continuous tubular member such that, when the continuous tubular member is subdivided and sealed into discrete pouch portions, each pouch portion includes a charge of a composition adapted for oral use.
  • Representative equipment for supplying the filler material is disclosed, for example, in U.S. Patent Application Publication No. US 2010/0018539 to Brinkley, which is incorporated herein by reference.
  • the apparatus may include a subdividing unit for subdividing the continuous tubular member into individual pouch portions and, once subdivided into the individual pouch portions, may also include a sealing unit for sealing at least one of the ends of each pouch portion.
  • the continuous tubular member may be sealed into individual pouch portions with a sealing unit and then, once the individual pouch portions are sealed, the continuous tubular member may be subdivided into discrete individual pouch portions by a subdividing unit subdividing the continuous tubular member between the sealed ends of serially-disposed pouch portions. Still in other instances, sealing (closing) of the individual pouch portions of the continuous tubular member may occur substantially concurrently with the subdivision thereof, using a closing and dividing unit.
  • an apparatus similar to that described in U.S. Publication No. 2012/0055493 can be configured to removably receive a first bobbin on an unwind spindle assembly, the first bobbin having a continuous length of a material, such as a pouch material, wound thereon.
  • the pouch material can be routed from the first bobbin to a forming unit configured to form a continuous supply of the pouch material into a continuous tubular member defining a longitudinal axis.
  • the pouch material can be directed around an arrangement of roller members, otherwise referred to herein as a dancer assembly.
  • a forming unit can be configured to cooperate with the first bobbin and the dancer assembly to take up slack in the pouch material and to maintain a certain amount of longitudinal tension on the pouch material as the pouch material is unwound from the first bobbin and fed to the forming unit, for example, by a drive system.
  • the pouch material can be supported, routed, and/or guided by a suitably aligned series of any number of, for example, idler rollers, guideposts, air bars, turning bars, guides, tracks, tunnels, or the like, for directing the pouch material along the desired path.
  • Typical bobbins used by conventional automated pouch making apparatuses often contain a continuous strip of pouch material of which the length may vary.
  • the apparatus described herein can be configured so as to handle bobbins of that type and size.
  • the forming unit can include one or more roller members configured to direct the pouch material about a hollow shaft such that the continuous supply of the pouch material can be formed into a continuous tubular member.
  • the forming unit can include a sealing device configured to seal, fix, or otherwise engage lateral edges of the pouch material to form a longitudinally-extending seam, thereby forming a longitudinally-extending continuous tubular member.
  • an insertion unit can be configured to introduce charges of the composition adapted for oral use into the continuous tubular member through the hollow shaft. The insertion unit may be directly or indirectly engaged with the hollow shaft.
  • a leading edge or end (also referred to as a laterally-extending seam) of the continuous tubular member can be closed/sealed such that a charge of composition adapted for oral use inserted by the insertion unit, is contained within the continuous tubular member proximate to the leading end.
  • the leading end can be closed/sealed via a closing and dividing unit configured to close/seal a first portion of the continuous tubular member to form the closed leading end of a pouch member portion.
  • the closing and dividing unit can also be configured to form a closed trailing edge or end of a previous pouch member portion.
  • the closing and dividing unit can also be configured to close a second portion of the continuous tubular member to form the closed trailing end of the pouch member portion.
  • the closing and dividing unit can close the ends, by heat-sealing, or other suitable sealing mechanism.
  • a binder coating is not necessary for embodiments of the present invention, Instead, a heat sealable binder fiber incorporated into the nonwoven web of the pouch material can act as a heat sealable binder to seal the pouch once the composition adapted for oral use is inserted within the outer water-permeable pouch.
  • the closing and dividing unit can be configured to divide the continuous tubular member, between the closed trailing end and the closed leading end of serially-disposed pouch member portions, along the longitudinal axis of the continuous tubular member, and into a plurality of discrete pouch member portions such that each discrete pouch member portion includes a portion of the oral composition from the insertion unit.
  • the closing and dividing unit can include a blade, heated wire, or other cutting arrangement for severing the continuous tubular member into discrete pouch member portions.
  • the closing and dividing unit can include first and second arm members configured to interact to close and divide the continuous tubular member.
  • a charge of the composition adapted for oral use i.e., an amount suitable for an individual pouch member portion
  • the discrete individual pouch member portion can be formed by closing the trailing end and severing the closed pouch member portion from the continuous tubular member such that an individual pouched product is formed.
  • each pouch/container may have disposed therein a flavor agent member, as described in greater detail in U.S. Pat. No. 7,861,728 to Holton, Jr. et al., which is incorporated herein by reference.
  • a flavor agent member as described in greater detail in U.S. Pat. No. 7,861,728 to Holton, Jr. et al., which is incorporated herein by reference.
  • at least one flavored strip, piece or sheet of flavored water dispersible or water soluble material may be disposed within each pouch along with or without at least one capsule.
  • Such strips or sheets may be folded or crumpled in order to be readily incorporated within the pouch. See, for example, the types of materials and technologies set forth in U.S. Pat. No. 6,887,307 to Scott et al. and U.S. Pat. No. 6,923,981 to Leung et al.; and The EFSA Journal (2004) 85, 1-32; which are incorporated herein by reference.
  • the nonwoven web can be sufficiently tacky so as to create issues with high-speed pouching equipment. Therefore, in certain embodiments, a Teflon coating, or similar material, can be applied to one or more surfaces of the pouching equipment that touch the nonwoven web such as, for example, rollers, cutting instruments, and heat sealing devices in order to reduce and/or alleviate any problems associated with the pouch material sticking to the pouching equipment during processing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicinal Preparation (AREA)
US14/561,736 2014-12-05 2014-12-05 Smokeless tobacco pouch Abandoned US20160157515A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US14/561,736 US20160157515A1 (en) 2014-12-05 2014-12-05 Smokeless tobacco pouch
EP24179307.4A EP4442128A1 (fr) 2014-12-05 2015-12-03 Sachet de tabac sans fumée
PCT/US2015/063592 WO2016090075A1 (fr) 2014-12-05 2015-12-03 Sachet de tabac sans fumée
JP2017529638A JP6854760B2 (ja) 2014-12-05 2015-12-03 無煙タバコ用小袋
DK15816994.6T DK3226700T3 (da) 2014-12-05 2015-12-03 Røgfri tobakspose
EP15816994.6A EP3226700B1 (fr) 2014-12-05 2015-12-03 Sachet de tabac sans fumée
CN201580075231.1A CN107205471A (zh) 2014-12-05 2015-12-03 无烟烟草袋
CN202211208329.8A CN115517405A (zh) 2014-12-05 2015-12-03 无烟烟草袋
JP2021041038A JP7485628B2 (ja) 2014-12-05 2021-03-15 無煙タバコ用小袋
US17/363,174 US11344057B2 (en) 2014-12-05 2021-06-30 Capsule-containing pouched product for oral use
US17/737,680 US11832640B2 (en) 2014-12-05 2022-05-05 Capsule-containing pouched product for oral use
US18/389,152 US20240074481A1 (en) 2014-12-05 2023-11-13 Capsule-containing pouched product for oral use
JP2024074696A JP2024105405A (ja) 2014-12-05 2024-05-02 無煙タバコ用小袋

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/561,736 US20160157515A1 (en) 2014-12-05 2014-12-05 Smokeless tobacco pouch

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/363,174 Continuation US11344057B2 (en) 2014-12-05 2021-06-30 Capsule-containing pouched product for oral use

Publications (1)

Publication Number Publication Date
US20160157515A1 true US20160157515A1 (en) 2016-06-09

Family

ID=55025397

Family Applications (4)

Application Number Title Priority Date Filing Date
US14/561,736 Abandoned US20160157515A1 (en) 2014-12-05 2014-12-05 Smokeless tobacco pouch
US17/363,174 Active US11344057B2 (en) 2014-12-05 2021-06-30 Capsule-containing pouched product for oral use
US17/737,680 Active US11832640B2 (en) 2014-12-05 2022-05-05 Capsule-containing pouched product for oral use
US18/389,152 Pending US20240074481A1 (en) 2014-12-05 2023-11-13 Capsule-containing pouched product for oral use

Family Applications After (3)

Application Number Title Priority Date Filing Date
US17/363,174 Active US11344057B2 (en) 2014-12-05 2021-06-30 Capsule-containing pouched product for oral use
US17/737,680 Active US11832640B2 (en) 2014-12-05 2022-05-05 Capsule-containing pouched product for oral use
US18/389,152 Pending US20240074481A1 (en) 2014-12-05 2023-11-13 Capsule-containing pouched product for oral use

Country Status (6)

Country Link
US (4) US20160157515A1 (fr)
EP (2) EP3226700B1 (fr)
JP (3) JP6854760B2 (fr)
CN (2) CN107205471A (fr)
DK (1) DK3226700T3 (fr)
WO (1) WO2016090075A1 (fr)

Cited By (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160128294A1 (en) * 2014-11-10 2016-05-12 R.J. Reynolds Tobacco Company Infused plant seeds
USD777975S1 (en) * 2012-07-30 2017-01-31 British American Tobacco (Investments) Limited Tobacco pouch
US9913491B2 (en) 2012-07-30 2018-03-13 British American Tobacco (Investments) Limited Fleece for smokeless tobacco
WO2018092035A1 (fr) 2016-11-15 2018-05-24 Rai Strategic Holdings, Inc. Communication en champ proche pour un article à base de tabac ou son emballage
US20180140007A1 (en) * 2015-04-17 2018-05-24 Swedish Match North Europe Ab Oral pouched product having a rectangular shape
US20180279673A1 (en) * 2017-03-29 2018-10-04 Rai Strategic Holdings, Inc. Aerosol delivery device including substrate with improved absorbency properties
USD837447S1 (en) * 2015-04-17 2019-01-01 Swedish Match North Europe Ab Oral snuff package
USD868369S1 (en) * 2015-12-02 2019-11-26 Swedish Match North Europe Ab Snuff pouch
WO2021048769A1 (fr) 2019-09-13 2021-03-18 Nicoventures Trading Limited Procédé de blanchiment de tabac
WO2021048768A1 (fr) 2019-09-11 2021-03-18 Nicoventures Trading Limited Procédé de blanchiment de tabac
WO2021048770A1 (fr) 2019-09-11 2021-03-18 Nicoventures Trading Limited Procédés alternatifs de blanchiment du tabac
WO2021050741A1 (fr) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Produit oral comprenant une amine basique et un agent d'appariement d'ions
WO2021086367A1 (fr) 2019-10-31 2021-05-06 Nicoventures Trading Limited Produit oral et son procédé de fabrication
EP3784064B1 (fr) 2019-03-18 2021-06-02 Swedish Match North Europe AB Matériau d'emballage et produit à base de nicotine en sachet destiné à être administré par voie orale
US20210169125A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral products with controlled release
US20210169138A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
US20210170031A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
WO2021116823A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit oral
WO2021116826A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral comprenant un cannabinoïde
WO2021116834A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nanoémulsion à usage oral
WO2021116824A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral comprenant un cannabinoïde
WO2021116890A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition liquide à utilisation orale ou destinée à être utilisée dans un dispositif de distribution d'aérosol
WO2021116918A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales comprenant des gels
WO2021116919A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Non-tissé pour produit oral avec composant libérable
WO2021116892A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales à activité de l'eau réduite
WO2021116867A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions à usage oral tamponnées
WO2021116837A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits en sachet
WO2021116862A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales à teneur en eau réduite
WO2021116895A2 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Sachet sensible à un stimulus
WO2021116868A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à libération contrôlée
WO2021116878A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à liaison améliorée d'ingrédients actifs
WO2021116822A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à irritation réduite
WO2021116841A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales humides
WO2021116884A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nappe en couches pour produit en sachet
WO2021116842A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits à usage oral à libération contrôlée
WO2021116825A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral
WO2021116827A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Procédé
WO2021116856A2 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits à usage oral
WO2021116916A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit oral avec de multiples arômes ayant différents profils de libération
WO2021116881A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral en sachet poreux comprenant un matériau non-tissé
WO2021116876A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition à usage oral avec inclusion de sel
WO2021116866A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits en sachet à stabilité de saveur améliorée
WO2021116865A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents pour composition orale
WO2021116879A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition à usage oral comprenant une substance de betterave
WO2021171185A1 (fr) 2020-02-24 2021-09-02 Nicoventures Trading Limited Matériau de tabac sous forme de billes et procédé de fabrication associé
WO2021244892A1 (fr) * 2020-06-03 2021-12-09 Swedish Match North Europe Ab Matériau d'emballage et produit en sachet pour utilisation par voie orale
WO2021250516A1 (fr) 2020-06-08 2021-12-16 Nicoventures Trading Limited Composition orale effervescente comprenant un principe actif
WO2022043700A1 (fr) 2020-08-27 2022-03-03 Nicoventures Trading Limited Produit oral
WO2022049536A1 (fr) 2020-09-04 2022-03-10 Nicoventures Trading Limited Procédé de blanchissement de tabac
WO2022053982A1 (fr) 2020-09-11 2022-03-17 Nicoventures Trading Limited Substrats à base d'alginate
WO2022107031A1 (fr) 2020-11-19 2022-05-27 Nicoventures Trading Limited Produits à usage oral
US20220295861A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US20220295874A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral product with sustained flavor release
WO2022229929A1 (fr) 2021-04-30 2022-11-03 Nicoventures Trading Limited Produits destinés à être administrés par voie orale à charge de haute densité
WO2022234522A1 (fr) 2021-05-06 2022-11-10 Nicoventures Trading Limited Compositions orales et procédés associés pour réduire l'irritation de la gorge
WO2022264066A1 (fr) 2021-06-16 2022-12-22 Nicoventures Trading Limited Produit en sachet comprenant une composition soluble
WO2022269556A1 (fr) 2021-06-25 2022-12-29 Nicoventures Trading Limited Produits pour voie buccale et procédé de fabrication
WO2023281469A1 (fr) 2021-07-09 2023-01-12 Nicoventures Trading Limited Structures extrudées
WO2023053062A1 (fr) 2021-09-30 2023-04-06 Nicoventures Trading Limited Produit oral comprenant une amine basique et un agent d'appariement d'ions
EP3992093B1 (fr) 2020-10-29 2023-06-07 Swedish Match North Europe AB Produit à usage oral en sachet, procédé d'étanchéité, dispositif d'étanchéité, procédé et appareil de fabrication d'un produit à usage oral en sachet
US20230180816A1 (en) * 2020-04-27 2023-06-15 Nonwovenn Ltd Nonwoven fabric for oral pouched product, and methods of manufacturing a nonwoven fabric
US20230249899A1 (en) * 2020-07-30 2023-08-10 Tenowo GmbH Moisture-permeable, microporous luxury food packaging material made of nonwoven fabric
US20230292827A1 (en) * 2022-03-21 2023-09-21 Lucy Goods, Inc. Nicotine pouch with capsule having mct oil
WO2023187675A1 (fr) 2022-03-31 2023-10-05 R. J. Reynolds Tobacco Company Matériau botanique aggloméré pour produits oraux
US11794985B2 (en) * 2016-04-29 2023-10-24 Ahlstrom Oyj Compostable lid intended to seal a capsule and a capsule sealed by the lid
US11826462B2 (en) * 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11832640B2 (en) 2014-12-05 2023-12-05 R.J. Reynolds Tobacco Company Capsule-containing pouched product for oral use
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US11844368B2 (en) 2017-12-15 2023-12-19 Swedish Match North Europe Ab Flavoured moist oral pouched nicotine product comprising monoglyceride
WO2023248187A1 (fr) 2022-06-24 2023-12-28 Nicoventures Trading Limited Composition orale comprenant un modulateur de récepteur
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11896711B2 (en) 2019-12-09 2024-02-13 Nicoventures Trading Limited Process of making nanoemulsion
EP4072350A4 (fr) * 2019-12-09 2024-03-06 Nicoventures Trading Limited Produits en sachet
WO2024074842A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit à administration par voie orale
WO2024074836A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074835A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit destiné à la voie orale
WO2024074839A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074834A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074843A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit à administration par voie orale
WO2024079722A1 (fr) * 2022-10-14 2024-04-18 Nicoventures Trading Limited Produits en sachet contenant des capsules
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
WO2024095162A1 (fr) 2022-11-01 2024-05-10 Nicoventures Trading Limited Procédé de préparation d'un produit en sachet comprenant un sel de nicotine
WO2024095013A1 (fr) 2022-11-04 2024-05-10 Nicoventures Trading Limited Produit à administration orale
WO2024095163A1 (fr) 2022-11-01 2024-05-10 Nicoventures Trading Limited Composition orale comprenant un agent d'ajustement de ph encapsulé
WO2024095011A1 (fr) 2022-11-04 2024-05-10 Nicoventures Trading Limited Produit à administration par voie orale
WO2024171117A1 (fr) 2023-02-15 2024-08-22 Nicoventures Trading Limited Produits oraux à charge de haute densité
WO2024180481A1 (fr) 2023-02-28 2024-09-06 Nicoventures Trading Limited Produit à prendre par voie orale contenant de la caféine
WO2024201031A1 (fr) 2023-03-27 2024-10-03 Nicoventures Trading Limited Produit oral pour l'administration d'agents actifs
USD1049470S1 (en) 2021-05-05 2024-10-29 Lucy Goods Inc. Nicotine pouch
US12138342B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Fleece for oral product with releasable component
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
WO2024236293A1 (fr) 2023-05-16 2024-11-21 Nicoventures Trading Limited Produit oral
WO2024236294A1 (fr) 2023-05-16 2024-11-21 Nicoventures Trading Limited Produit à administration par voie orale
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
US12178905B2 (en) 2019-12-09 2024-12-31 Nicoventures Trading Limited Fleece for pouched product with controlled basis weight
US12274779B2 (en) 2020-06-08 2025-04-15 Nicoventures Trading Limited Effervescent oral composition
US12310394B2 (en) 2021-07-30 2025-05-27 Nicoventures Trading Limited Aerosol-generating substrate comprising microcrystalline cellulose
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
US12344459B2 (en) 2017-04-28 2025-07-01 Ahlstrom Oyj Compostable lid comprising an oxygen barrier layer for sealing a capsule and capsule sealed by the lid
EP4578301A2 (fr) 2019-12-09 2025-07-02 Nicoventures Trading Limited Produits oraux
WO2025141419A1 (fr) 2023-12-28 2025-07-03 American Snuff Company, Llc Procédé de fermentation en masses de tabac
EP4585059A1 (fr) 2024-01-12 2025-07-16 Nicoventures Trading Limited Produit effervescent en sachet
EP4600415A1 (fr) * 2024-02-09 2025-08-13 pely-tex GmbH & Co. KG Sachet comprenant une enveloppe en non-tissé perméable à l'eau et/ou à la vapeur d'eau et un matériau de remplissage pour application orale ou autres applications à libération contrôlée de principes actifs et procédé de fabrication d'un tel sachet
EP4623702A1 (fr) 2024-03-27 2025-10-01 Nicoventures Trading Limited Produit oral
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
EP4631502A1 (fr) 2024-04-12 2025-10-15 Nicoventures Trading Limited Utilisation de flavones telles que la quercétine pour augmenter la fonction cognitive et réduire la nervosité
EP4640076A1 (fr) 2024-04-22 2025-10-29 Nicoventures Trading Limited Produit oral avec émulsion d'arôme
EP4640072A1 (fr) 2024-04-24 2025-10-29 Nicoventures Trading Limited Tissus non tissés traités avec un agent d'appariement d'ions et produits oraux comprenant des tissus non tissés traités avec un agent d'appariement d'ions
EP4640075A1 (fr) 2024-04-22 2025-10-29 Nicoventures Trading Limited Produit en sachet oral avec système d'administration auto-émulsifiant
US12471618B2 (en) 2019-12-09 2025-11-18 Nicoventures Trading Limited Stimulus-responsive pouch
US12496276B2 (en) 2021-02-09 2025-12-16 Nicoventures Trading Limited Agents for oral composition

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3192380B1 (fr) 2016-01-12 2020-11-11 Swedish Match North Europe AB Produit en sachet oral
GB201705693D0 (en) * 2017-04-07 2017-05-24 Sensus Invest Ltd Carrier, apparatus and method
PL3614869T3 (pl) 2017-04-24 2025-02-10 Swedish Match North Europe Ab Aromatyzowany wilgotny doustny produkt nikotynowy w saszetce zawierający trójgliceryd
DE102017127434A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Taschenförmige oral auflösende Filme mit hoher Wirkstoffbeladung
GB201803328D0 (en) * 2018-03-01 2018-04-18 British American Tobacco Investments Ltd A gel composition and tobacco industry products including the same
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
SE543542C2 (en) 2019-02-19 2021-03-23 Swedish Match North Europe Ab Arrangement and method for manufacturing of a web of packaging material for an oral pouched snuff product
EP3955754A4 (fr) 2019-05-08 2023-01-04 Gamot Global Pte. Ltd. Utilisation d'isothiocyanate dans des produits de tabac sans fumée
DK180339B1 (en) 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
US11930838B2 (en) * 2019-06-07 2024-03-19 Philip Morris Products S.A. Pouched product with liquid flavor composition
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
GB202018694D0 (en) * 2020-11-27 2021-01-13 Nonwovenn Ltd Chewable product for oral delivery of a substance, and method of manufacturing the same
EP4018847B1 (fr) * 2020-12-22 2024-09-18 Swedish Match North Europe AB Produit à usage oral en sachet
JP2024105737A (ja) * 2021-03-30 2024-08-07 日本たばこ産業株式会社 口腔用パウチ製品、及び口腔用パウチ製品の製造方法
JP2025119065A (ja) * 2022-04-28 2025-08-14 日本たばこ産業株式会社 口腔用組成物
GB2635393A (en) * 2023-11-10 2025-05-14 Henry Netscher Adam Pouch

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060037620A1 (en) * 2004-08-18 2006-02-23 Thompson Bruce T Process to remove protein and other biomolecules from tobacco extract or slurry
US20070062549A1 (en) * 2005-09-22 2007-03-22 Holton Darrell E Jr Smokeless tobacco composition
US20100126520A1 (en) * 2007-01-17 2010-05-27 Peter Clayton Tobacco Product, Preparation and Uses Thereof
US20110083680A1 (en) * 2009-10-09 2011-04-14 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
US20110180087A1 (en) * 2008-12-30 2011-07-28 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US20110236442A1 (en) * 2010-03-26 2011-09-29 Philip Morris Usa Inc. Solid oral sensorial products including stain inhibitor
US20110247640A1 (en) * 2010-04-08 2011-10-13 R. J. Reynolds Tobacco Company Smokeless Tobacco Composition Comprising Tobacco-Derived Material and Non-Tobacco Plant Material
US20110303232A1 (en) * 2010-04-12 2011-12-15 Altria Client Services Inc. Pouch product with improved seal and method
US20120042883A1 (en) * 2010-08-17 2012-02-23 Internationl Oddities, Inc. Composite Packaging System For Particulate Smokable Product
US20120067362A1 (en) * 2010-09-13 2012-03-22 Michele Mola Smokeless Oral Products
US20120073589A1 (en) * 2009-07-02 2012-03-29 Norio Kawata Oral tobacco product
US20120073590A1 (en) * 2009-06-16 2012-03-29 Norio Kawata Oral tobacco article
US20120103353A1 (en) * 2010-11-01 2012-05-03 Sebastian Andries D Smokeless tobacco products
US20120247492A1 (en) * 2010-03-26 2012-10-04 Philip Morris Usa Inc. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
US20120291794A1 (en) * 2010-02-05 2012-11-22 Norio Kawata Oral tobacco product
US20120291793A1 (en) * 2011-05-19 2012-11-22 R.J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
US20120298124A1 (en) * 2010-01-28 2012-11-29 Hiroki Shikata Portion tobacco product
US20130152953A1 (en) * 2011-12-14 2013-06-20 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US20140271791A1 (en) * 2013-03-15 2014-09-18 Altria Client Services Inc. Oral energy products including encapsulated caffeine
US20140261480A1 (en) * 2013-03-15 2014-09-18 Altria Client Services Inc. Pouch material for smokeless tobacco and tobacco substitute products

Family Cites Families (230)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US338992A (en) 1886-03-30 Process of and apparatus for manufacturing gas
US2033909A (en) 1934-12-19 1936-03-17 Niacet Chemicals Corp Manufacture of calcium levulinate
US2475241A (en) 1945-02-01 1949-07-05 William A Hermanson Heat sealed bag
US3502763A (en) 1962-02-03 1970-03-24 Freudenberg Carl Kg Process of producing non-woven fabric fleece
US3390686A (en) 1965-12-21 1968-07-02 American Tobacco Co Tobacco smoke filter element
US3339558A (en) 1966-10-28 1967-09-05 Haskett Barry F Smoking article and filter therefor containing vitamin a
US3341394A (en) 1966-12-21 1967-09-12 Du Pont Sheets of randomly distributed continuous filaments
US3542615A (en) 1967-06-16 1970-11-24 Monsanto Co Process for producing a nylon non-woven fabric
US3550598A (en) 1967-08-15 1970-12-29 James H Mcglumphy Reconstituted tobacco containing adherent encapsulated flavors and other matter
US3849241A (en) 1968-12-23 1974-11-19 Exxon Research Engineering Co Non-woven mats by melt blowing
DE2048006B2 (de) 1969-10-01 1980-10-30 Asahi Kasei Kogyo K.K., Osaka (Japan) Verfahren und Vorrichtung zur Herstellung einer breiten Vliesbahn
DE1950669C3 (de) 1969-10-08 1982-05-13 Metallgesellschaft Ag, 6000 Frankfurt Verfahren zur Vliesherstellung
GB1273040A (en) 1969-12-18 1972-05-03 Procter & Gamble Coffee-brewing packet
US3685521A (en) 1970-06-16 1972-08-22 H 2 O Filter Corp The Cigarette holder containing actuated carbon and frangible capsule
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
JPS4820475B1 (fr) 1970-08-25 1973-06-21
GB1400278A (en) 1972-06-06 1975-07-16 British American Tobacco Co Smoking articles
US3972759A (en) 1972-06-29 1976-08-03 Exxon Research And Engineering Company Battery separators made from polymeric fibers
IT1192247B (it) 1978-02-24 1988-03-31 Snia Viscosa Procedimento per la preparazione di derivati della cellulosa coagulabili e filabili con rigenerazione della cellulosa stessa
IT7821922A0 (it) 1978-04-03 1978-04-03 Ind Applic Viscosa Snia Viscos Procedimento per la dissoluzione della cellulosa in solventi organici, soluzioni ottenute con tale procedimento, e procedimento per la rigenerazione della cellulosa dalle dette soluzioni con produzioni di corpi formati.
IT7826174A0 (it) 1978-07-27 1978-07-27 Snia Viscosa Procedimento per la preparazione di corpi formati di cellulosa rigenerata da soluzioni di derivati della cellulosa in dimetilsolfossido.
CA1141114A (fr) 1978-11-24 1983-02-15 Masamichi Ishida Fibre creuse en cellulose regeneree et procede de fabrication
US4340563A (en) 1980-05-05 1982-07-20 Kimberly-Clark Corporation Method for forming nonwoven webs
JPS5860010A (ja) 1981-10-01 1983-04-09 Asahi Chem Ind Co Ltd 中空糸およびその中空糸からなる透析膜
DK149920C (da) 1983-09-20 1987-05-18 Krueger S Eftf A S Hermann Fremgangsmaade ved portionering af snus og emballering af de enkelte snusportioner
SE450566B (sv) 1983-12-14 1987-07-06 Svenska Tobaks Ab Anordning for att portionsforpacka snus
US4800903A (en) 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
US4622259A (en) 1985-08-08 1986-11-11 Surgikos, Inc. Nonwoven medical fabric
ZA87623B (en) 1986-03-10 1987-11-25 Gen Electric Apparatus for monitoring temperatures of implements during brazing
US4771795A (en) 1986-05-15 1988-09-20 R. J. Reynolds Tobacco Company Smoking article with dual burn rate fuel element
US5004595A (en) 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4830028A (en) 1987-02-10 1989-05-16 R. J. Reynolds Tobacco Company Salts provided from nicotine and organic acid as cigarette additives
KR910000142B1 (ko) 1987-05-29 1991-01-21 니혼 다바고 상교오 가부시기가이샤 담배용 필터
US5074321A (en) 1989-09-29 1991-12-24 R. J. Reynolds Tobacco Company Cigarette
US6056992A (en) 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5105836A (en) 1989-09-29 1992-04-21 R. J. Reynolds Tobacco Company Cigarette and smokable filler material therefor
US5167244A (en) 1990-01-19 1992-12-01 Kjerstad Randy E Tobacco substitute
US5027837A (en) 1990-02-27 1991-07-02 R. J. Reynolds Tobacco Company Cigarette
US5200246A (en) 1991-03-20 1993-04-06 Tuff Spun Fabrics, Inc. Composite fabrics comprising continuous filaments locked in place by intermingled melt blown fibers and methods and apparatus for making
JP3159724B2 (ja) 1991-04-19 2001-04-23 フロイント産業株式会社 シームレスカプセル製造方法および装置
US5186948A (en) 1991-05-28 1993-02-16 Freund Inphachem Inc. Apparatus for manufacturing seamless capsules
GB9125594D0 (en) 1991-12-02 1992-01-29 Courtaulds Plc Purifying solutions
US5334446A (en) 1992-01-24 1994-08-02 Fiberweb North America, Inc. Composite elastic nonwoven fabric
US5759599A (en) 1992-03-30 1998-06-02 Givaudan Roure Flavors Corporation Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils
AU675573B2 (en) 1993-09-30 1997-02-06 British-American Tobacco Company Limited Improvements relating to tobacco smoke filter elements
US5690990A (en) 1994-03-04 1997-11-25 Arnhem, Inc. Process for encapsulating the flavor with colloid gel matrix
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5630978A (en) 1995-06-07 1997-05-20 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Preparation of biologically active molecules by molecular imprinting
NL1001692C2 (nl) 1995-11-20 1997-05-21 Akzo Nobel Nv Werkwijze voor de bereiding van geregenereerde cellulose filamenten.
JP3759986B2 (ja) 1995-12-07 2006-03-29 フロイント産業株式会社 シームレスカプセルおよびその製造方法
JP3881699B2 (ja) 1996-10-09 2007-02-14 ジボーダン―ルール（アンテルナシヨナル）ソシエテ アノニム 食品添加剤としてのビーズの製造方法
ID21348A (id) 1996-10-09 1999-05-27 Givaudan Roure Int Proses untuk pembuatan butiran-butiran sebagai aditif makanan atau tembakau
GB9623924D0 (en) 1996-11-18 1997-01-08 Bonded Fibre Fab A high durability nonwoven fabric
US6039901A (en) 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US6106875A (en) 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6045835A (en) 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
EP1054092A1 (fr) 1999-05-17 2000-11-22 Nippon Petrochemicals Company, Limited Feuille composite élastique, bande élastique en élastomère thermoplastique, méthode et appareil de fabrication
ZA200003120B (en) 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
PT1204699E (pt) 1999-07-22 2005-08-31 Warner Lambert Co Composicoes para peliculas a base de pululano
SE9903958D0 (sv) 1999-11-02 1999-11-02 Boerje Sellergren Porous materials for selective binding or transport of molecular guests
TWI227170B (en) 1999-12-20 2005-02-01 Chugai Pharmaceutical Co Ltd The process for preparation of seamless capsules
SE0001877D0 (sv) 2000-05-22 2000-05-22 Klaus Mosbach Molecular imprinting
NZ505525A (en) 2000-06-30 2003-03-28 Horticulture & Food Res Inst Polymers imprinted with phenols for the binding of phenols, and a method and sensor for the detection and/or measurement of a phenol by measuring the binding of phenol to the polymer
EP1322191B2 (fr) * 2000-10-05 2018-08-01 Schweitzer-Mauduit International, Inc. Reduction de nitrosamines dans le tabac et dans des produits a base de tabac
US6612429B2 (en) 2001-06-22 2003-09-02 Brown & Williamson Tobacco Corporation Flip open package with microencapsulated flavor release
KR20030009800A (ko) 2001-07-24 2003-02-05 김진희 담배맛 변경이 가능한 담배
US7032601B2 (en) 2001-09-28 2006-04-25 U.S. Smokeless Tobacco Company Encapsulated materials
FR2832632B1 (fr) 2001-11-26 2004-04-23 Mane Fils V Capsule a solubilisation et liberation du contenu rapides
EP1458252B1 (fr) 2001-12-21 2008-01-23 Galenica AB Tabac et/ou substitut de tabac en combinaison avec du tabac s'utilisant comme tabac a priser dans la cavite buccale
US6949256B2 (en) 2002-01-18 2005-09-27 Banner Pharmacaps, Inc. Non-gelatin capsule shell formulation
EP1553224B1 (fr) 2002-07-01 2011-09-28 Asahi Kasei Fibers Corporation Non-tisse et sachet de the
EP1572164A2 (fr) 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Formes posologiques orales comprenant des agents actifs au plan therapeutique dans des noyaux a liberation lente et des revetements de capsule en gelatine a liberation immediate
US20040118421A1 (en) 2002-12-19 2004-06-24 Swedish Match North Europe Ab New product and a method for its manufacture
US20040118422A1 (en) 2002-12-19 2004-06-24 Swedish Match North Europe Ab Tobacco dough and a method for its manufacture
PT1578422E (pt) 2002-12-20 2007-06-14 Niconovum Ab Material particulado contendo nicotina fisicamente e quimicamente estável
US6958103B2 (en) 2002-12-23 2005-10-25 Kimberly-Clark Worldwide, Inc. Entangled fabrics containing staple fibers
US7913700B2 (en) * 2002-12-31 2011-03-29 Smokey Mountain Chew, Inc. Nontobacco moist snuff composition
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
MXPA05008918A (es) 2003-02-24 2006-02-17 Pharmaceutical Productions Inc Sistema de administracion transmucosal de farmacos.
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US7836895B2 (en) 2003-06-23 2010-11-23 R. J. Reynolds Tobacco Company Filtered cigarette incorporating a breakable capsule
US7115085B2 (en) 2003-09-12 2006-10-03 R.J. Reynolds Tobacco Company Method and apparatus for incorporating objects into cigarette filters
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8381738B2 (en) * 2003-12-22 2013-02-26 Philip Morris Usa Inc. Composite materials and their use in smoking articles
AU2004308498A1 (en) 2003-12-22 2005-07-14 U.S. Smokeless Tobacco Company Conditioning process for tobacco and/or snuff compositions
US20050196437A1 (en) 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US20050241657A1 (en) * 2004-04-29 2005-11-03 Brown & Williamson Tabacco Corporation Removal of nitrogen containing compounds from tobacco
EP1593376A1 (fr) 2004-05-04 2005-11-09 Warner-Lambert Company LLC Gélules de pullulane ameliorées
DE102004049805A1 (de) 2004-10-12 2006-04-13 Universität Dortmund Verfahren zur Herstellung von molekulargeprägten Polymeren zur Erkennung von Zielmolekülen
US10285431B2 (en) 2004-12-30 2019-05-14 Philip Morris Usa Inc. Encapsulated flavorant designed for thermal release and cigarette bearing the same
US7578298B2 (en) 2005-02-04 2009-08-25 Philip Morris Usa Inc. Flavor capsule for enhanced flavor delivery in cigarettes
NZ562668A (en) 2005-04-29 2010-12-24 Philip Morris Prod Tobacco pouch product
US7878962B2 (en) 2005-05-03 2011-02-01 Philip Morris Usa Inc. Cigarettes and filter subassemblies with squeezable flavor capsule and methods of manufacture
WO2006119660A1 (fr) 2005-05-11 2006-11-16 Givaudan Sa Procede d'encapsulation
WO2006136197A1 (fr) 2005-06-21 2006-12-28 V. Mane Fils Produit a fumer comprenant une capsule cassante, capsule cassante et procede de fabrication de cette capsule
CA2612665C (fr) 2005-06-21 2013-01-15 V. Mane Fils Dispositif pour fumeur incorporant une capsule frangible, capsule frangible et procede de fabrication de ladite capsule
WO2006136199A1 (fr) 2005-06-21 2006-12-28 V.Mane Fils Article pour fumeur contenant une capsule frangible, capsule frangible et procede de fabrication associe
EP1754419A1 (fr) 2005-08-15 2007-02-21 Philip Morris Products S.A. Dispositif pour la liberation de liquide dans un article à fumer
US7861728B2 (en) 2006-02-10 2011-01-04 R.J. Reynolds Tobacco Company Smokeless tobacco composition having an outer and inner pouch
JP5066092B2 (ja) 2005-09-22 2012-11-07 アール・ジエイ・レイノルズ・タバコ・カンパニー 無煙タバコ組成物
US7479098B2 (en) 2005-09-23 2009-01-20 R. J. Reynolds Tobacco Company Equipment for insertion of objects into smoking articles
US9060545B2 (en) 2005-11-01 2015-06-23 Philip Morris Usa Inc. Smoking article with manually releasable odorant
CN101370477A (zh) 2006-01-20 2009-02-18 莫诺索尔克斯有限公司 薄膜连接的包装及其制备方法
US7810507B2 (en) * 2006-02-10 2010-10-12 R. J. Reynolds Tobacco Company Smokeless tobacco composition
CA2646942C (fr) 2006-03-16 2014-07-29 Niconovum Ab Composition amelioree de tabac a priser
WO2007109892A1 (fr) * 2006-03-27 2007-10-04 Les Technologies Biofiltre Inc. Extraits de plante et leurs utilisations dans des systèmes de filtre
ATE446355T1 (de) 2006-04-10 2009-11-15 Reynolds Tobacco Co R Verfahren zur selektiven entfernung von safrol aus muskatöl
SE529886C2 (sv) * 2006-04-28 2007-12-18 Swedish Match North Europe Ab En ny metod för framställning av en fuktsnuskomposition som inte innehåller tobak
US20080029116A1 (en) 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
US20080085649A1 (en) 2006-10-06 2008-04-10 Jaime Marco Vara Salamero High tensile modulus nonwoven fabric for cleaning printer machines
GB0622252D0 (en) 2006-11-08 2006-12-20 British American Tobacco Co Materials and method for agglomeration of tobacco particles
ITBO20060792A1 (it) 2006-11-22 2008-05-23 Acma S P A Metodo per la produzione di bustine di materiale incoerente.
ITBO20060791A1 (it) 2006-11-22 2008-05-23 Acma S P A Macchina per la produzione di bustine di materiale incoerente
TWI421037B (zh) * 2006-12-07 2014-01-01 British American Tobacco Co 選作為煙草特異性亞硝胺類之分子拓印的聚合物及使用其之方法
US20080156338A1 (en) 2006-12-28 2008-07-03 Philip Morris Usa Inc. Sterilized moist snuff and method
US8177938B2 (en) 2007-01-19 2012-05-15 Georgia-Pacific Consumer Products Lp Method of making regenerated cellulose microfibers and absorbent products incorporating same
US20080202532A1 (en) 2007-02-28 2008-08-28 Gary Wygal Method for portioning and depositing ground tobacco into containers
US8616221B2 (en) 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
GB0704095D0 (en) 2007-03-02 2007-04-11 Mars Inc Beverage preparation material
US8252876B2 (en) 2007-03-05 2012-08-28 Biotage Ab Imprinted polymers
ITBO20070197A1 (it) 2007-03-20 2008-09-21 Azionaria Costruzioni Acma Spa Macchina per la produzione di bustine di materiale incoerente.
ITBO20070196A1 (it) 2007-03-20 2008-09-21 Azionaria Costruzioni Acma Spa Macchina e metodo per la produzione di bustine di materiale incoerente.
DE102007016959A1 (de) 2007-04-05 2008-10-09 Mcairlaid's Vliesstoffe Gmbh & Co. Kg Faserstoffbahn
SE0701088L (sv) 2007-05-04 2008-09-23 British American Tobacco Co Metod för att framställa en potionerad rökfri tobaksprodukt
WO2008146160A2 (fr) 2007-05-31 2008-12-04 Philips Morris Products S.A. Dispositif pour dévier un produit d'un scellement
US8067046B2 (en) * 2007-06-08 2011-11-29 Philip Morris Usa Inc. Oral pouch product including soluble dietary fibers
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
US20080302682A1 (en) 2007-06-11 2008-12-11 Radi Medical Biodegradable Ab Pouch for tobacco or tobacco substitute
WO2009010875A2 (fr) * 2007-07-16 2009-01-22 Philip Morris Products S.A. Produit en sachet pour administration orale à joint revêtu
US8124147B2 (en) 2007-07-16 2012-02-28 Philip Morris Usa Inc. Oral pouch products with immobilized flavorant particles
US8061362B2 (en) 2007-07-23 2011-11-22 R. J. Reynolds Tobacco Company Smokeless tobacco composition
US7946295B2 (en) 2007-07-23 2011-05-24 R. J. Reynolds Tobacco Company Smokeless tobacco composition
FI20070705A7 (fi) * 2007-09-14 2009-06-02 Biohit Oyj Asetaldehydin sitominen suussa ja mahalaukussa
US9125434B2 (en) 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
ITBO20070688A1 (it) 2007-10-12 2009-04-13 Azionaria Costruzioni Acma Spa Macchina per la produzione di bustine contenenti una miscela di tabacco.
US8336557B2 (en) 2007-11-28 2012-12-25 Philip Morris Usa Inc. Smokeless compressed tobacco product for oral consumption
EP2219479B1 (fr) 2007-12-21 2018-08-15 Swedish Match North Europe AB Produit avec ou sans tabac comprenant du carbonate de magnésium
WO2009094859A1 (fr) 2008-01-25 2009-08-06 Rj Reynolds Tobacco Company Procédé de fabrication de capsules cassables utilisées dans des produits de tabac
DE102008015851A1 (de) 2008-03-27 2009-10-01 Herrmann Ultraschalltechnik Gmbh & Co. Kg Ultraschallschweißwerkzeug mit Fluidantrieb
US20100330236A1 (en) 2008-04-18 2010-12-30 Ohki Co. Ltd Fiber sheet
US20100018539A1 (en) 2008-07-28 2010-01-28 Paul Andrew Brinkley Smokeless tobacco products and processes
US20100018541A1 (en) 2008-07-28 2010-01-28 Anthony Richard Gerardi Smokeless tobacco products and processes
WO2010014506A2 (fr) 2008-07-28 2010-02-04 R.J. Reynolds Tobacco Company Produits du tabac sans fumée et procédés
WO2010031552A1 (fr) 2008-09-17 2010-03-25 Niconovum Ab Procédé de préparation d'une composition de tabac à priser
EP2364263B1 (fr) 2008-11-07 2013-05-22 Hauni Maschinenbau AG Dispositif et procédé de dosage de tabac en portions convenant pour le conditionnement
US9167835B2 (en) 2008-12-30 2015-10-27 Philip Morris Usa Inc. Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products
US8863755B2 (en) * 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
NO2405942T3 (fr) 2009-03-13 2018-03-31
US20100252056A1 (en) 2009-04-01 2010-10-07 Hauni Maschinenbau Ag Apparatus and method for metering oral tobacco in portions suitable for consumption
DE102009002675A1 (de) 2009-04-27 2010-10-28 Herrmann Ultraschalltechnik Gmbh & Co. Kg Ultraschallsiegelvorrichtung und Verfahren zum Versiegeln von Materialbahnen
JPWO2010147024A1 (ja) 2009-06-16 2012-12-06 日本たばこ産業株式会社 口腔用たばこ製品
JP2011000004A (ja) * 2009-06-16 2011-01-06 Japan Tobacco Inc 口腔用たばこ製品
US9848634B2 (en) 2009-06-30 2017-12-26 Philip Morris Products S.A. Smokeless tobacco product
US9010336B2 (en) * 2009-10-09 2015-04-21 Philip Morris Usa Inc. Coil packaging for smokeless tobacco
US8955523B2 (en) 2010-01-15 2015-02-17 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
SE534627C2 (sv) * 2010-02-17 2011-11-01 Swedish Match North Europe Ab Orala rökfria tobaksprodukter och orala rökfria icke tobaksinnehållande snusprodukter innehållande karbamid
US8602068B2 (en) 2010-03-26 2013-12-10 Philip Morris Usa Inc. Method and apparatus for pouching tobacco having a high moisture content
CA2796346C (fr) 2010-04-14 2018-10-02 Altria Client Services Inc. Produit de tabac sans fumee preforme
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
DE102010029243A1 (de) 2010-05-21 2011-11-24 Hauni Maschinenbau Ag Vorrichtung und Verfahren zum Zuführen von gemahlenem oder geschnittenem Tabakmaterial zu einer Portionierungsvorrichtung
US9066540B2 (en) 2010-08-05 2015-06-30 Altria Client Services Inc. Fabric having tobacco entangled with structural fibers
RU2562784C2 (ru) 2010-08-05 2015-09-10 Олтриа Клайент Сервисиз Инк. Композитные бездымные табачные изделия, системы и способы
US8828895B2 (en) 2010-08-25 2014-09-09 Nonwoven Network LLC Webs of bi-component and mono-component Co-PLA fibers
US10028520B2 (en) 2010-09-02 2018-07-24 R.J. Reynolds Tobacco Company Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method
GB201018292D0 (en) 2010-10-29 2010-12-15 Fiedler & Lundgren Ab Method and apparatus for production of smokeless tobacco products
WO2012078960A1 (fr) 2010-12-10 2012-06-14 Altria Client Services Inc. Système et procédé de conditionnement de tabac sans fumée
US9107453B2 (en) 2011-01-28 2015-08-18 R.J. Reynolds Tobacco Company Tobacco-derived casing composition
SE535587C2 (sv) 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
GB201113775D0 (en) 2011-08-10 2011-09-21 British American Tobacco Co Capsule formation
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) * 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
EP2589366A1 (fr) 2011-11-07 2013-05-08 IDT Biologika GmbH Emballage en film biodégradable pour agents biologiques oraux
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754907B (zh) 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103040090B (zh) 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
US12285025B2 (en) 2012-02-10 2025-04-29 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
WO2013142483A1 (fr) * 2012-03-19 2013-09-26 R. J. Reynolds Tobacco Company Procédé de traitement de pulpe de tabac extraite et produits de tabac fabriqués à l'aide de ce procédé
SE536491C2 (sv) 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
US9339058B2 (en) 2012-04-19 2016-05-17 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
GB2504495A (en) 2012-07-30 2014-02-05 British American Tobacco Co Fleece for smokeless tobacco pouch
US9386800B2 (en) 2012-09-21 2016-07-12 R.J. Reynolds Tobacco Company Fibrous composite tobacco-containing materials
GB201220280D0 (en) 2012-11-12 2012-12-26 British American Tobacco Co Products including capsules, uses and preparation thereof
TW201420054A (zh) 2012-11-21 2014-06-01 Kang Na Hsiung Entpr Co Ltd 吸濕用不織布及其製法
EP2967123B1 (fr) 2013-03-14 2025-01-01 Altria Client Services LLC Machines et procédés d'enrobage de partie de produit
US9402414B2 (en) 2013-03-14 2016-08-02 Altria Client Services Llc Smokeless tobacco article
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US9185931B2 (en) 2013-05-13 2015-11-17 Altria Client Services Inc. Oral product
EP3622834A1 (fr) 2013-07-19 2020-03-18 Altria Client Services LLC Procédés et systèmes pour incorporer de la nicotine dans des produits à usage oral
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US20150096574A1 (en) 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tobacco tablet
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US11771127B2 (en) 2013-10-03 2023-10-03 Altria Client Services Llc Chewable dissolvable nicotine tablet
US10071053B2 (en) 2014-01-31 2018-09-11 Pocket Tea, Llc Tea composition for oral administration
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3157361A1 (fr) 2014-06-18 2017-04-26 Swedish Match North Europe AB Produit avec du tabac ou sans tabac comprenant du carbonate de magnésium
US11019840B2 (en) 2014-07-02 2021-06-01 R.J. Reynolds Tobacco Company Oral pouch products
US10959456B2 (en) 2014-09-12 2021-03-30 R.J. Reynolds Tobacco Company Nonwoven pouch comprising heat sealable binder fiber
EP3223636B1 (fr) 2014-11-25 2020-03-04 Swedish Match North Europe AB Produit en sachet oral
US20160157515A1 (en) * 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
US9930914B2 (en) 2014-12-16 2018-04-03 Read Fisher Goode, JR. Seamless oral pouch product
SI3232825T1 (sl) 2014-12-19 2019-02-28 Swedish Match North Europe Ab Oralni brezdimni vlažen izdelek njuhanca
US20160192703A1 (en) 2015-01-07 2016-07-07 R.J. Reynolds Tobacco Company Oral pouch products
US9950858B2 (en) 2015-01-16 2018-04-24 R.J. Reynolds Tobacco Company Tobacco-derived cellulose material and products formed thereof
SE540515C2 (en) 2015-04-17 2018-09-25 Swedish Match North Europe Ab Oral pouched product having a rectangular shape
RU2711937C2 (ru) 2015-12-02 2020-01-23 Свидиш Мэтч Норт Юроп Аб Способ изготовления пакетированного изделия из снаффа для орального использования
RU2709953C1 (ru) 2015-12-02 2019-12-23 Свидиш Мэтч Норт Юроп Аб Пакетированное изделие из снаффа для перорального использования
US20170188622A1 (en) 2016-01-05 2017-07-06 R.J. Reynolds Tobacco Company Smokeless tobacco product
EP3192380B1 (fr) 2016-01-12 2020-11-11 Swedish Match North Europe AB Produit en sachet oral
US20180255801A1 (en) 2016-05-27 2018-09-13 Pocket Tea, Llc Compositions containing tea, tea-like or other non-tobacco leaf-like material
US10334873B2 (en) 2016-06-16 2019-07-02 Altria Client Services Llc Breakable capsules and methods of forming thereof
EP3330190A1 (fr) 2016-12-02 2018-06-06 Swedish Match North Europe AB Procédé et agencement pour l'emballage par portion d'un produit à priser emballé oral
AU2018221739A1 (en) 2017-02-15 2019-08-29 Molecular Infusions, Llc Formulations
WO2019036243A1 (fr) 2017-08-16 2019-02-21 Molecular Infusions, Llc Formulations
DE102017103599B4 (de) 2017-02-22 2021-12-30 Tkr Spezialwerkzeuge Gmbh Blockiereinheit für eine Hebevorrichtung sowie Hebevorrichtung für eine Kraftfahrzeugbaugruppe
PL3614869T3 (pl) 2017-04-24 2025-02-10 Swedish Match North Europe Ab Aromatyzowany wilgotny doustny produkt nikotynowy w saszetce zawierający trójgliceryd
US11406630B2 (en) 2017-06-23 2022-08-09 Ncp Nextgen A/S Nicotine pouch
EP3491940B1 (fr) 2017-11-29 2024-08-07 Reemtsma Cigarettenfabriken GmbH Procédé de fabrication d'un matériau de remplissage pour un produit à priser sans fumée en sachet et matériau de remplissage ainsi fabriqué
US11844368B2 (en) 2017-12-15 2023-12-19 Swedish Match North Europe Ab Flavoured moist oral pouched nicotine product comprising monoglyceride
SE543560C2 (en) 2019-02-19 2021-03-30 Swedish Match North Europe Ab A packaging material and an oral pouched snuff product
SE542990C2 (en) 2019-03-18 2020-09-22 Swedish Match North Europe Ab A packaging material and an oral pouched nicotine product
US11930838B2 (en) 2019-06-07 2024-03-19 Philip Morris Products S.A. Pouched product with liquid flavor composition
FI4072347T3 (fi) * 2019-12-09 2025-03-19 Nicoventures Trading Ltd Fleece irrotettavalla komponentilla oraalituotteeseen

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060037620A1 (en) * 2004-08-18 2006-02-23 Thompson Bruce T Process to remove protein and other biomolecules from tobacco extract or slurry
US20070062549A1 (en) * 2005-09-22 2007-03-22 Holton Darrell E Jr Smokeless tobacco composition
US20100126520A1 (en) * 2007-01-17 2010-05-27 Peter Clayton Tobacco Product, Preparation and Uses Thereof
US20110180087A1 (en) * 2008-12-30 2011-07-28 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US20120073590A1 (en) * 2009-06-16 2012-03-29 Norio Kawata Oral tobacco article
US20120073589A1 (en) * 2009-07-02 2012-03-29 Norio Kawata Oral tobacco product
US20110083680A1 (en) * 2009-10-09 2011-04-14 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
US20120298124A1 (en) * 2010-01-28 2012-11-29 Hiroki Shikata Portion tobacco product
US20120291794A1 (en) * 2010-02-05 2012-11-22 Norio Kawata Oral tobacco product
US20110236442A1 (en) * 2010-03-26 2011-09-29 Philip Morris Usa Inc. Solid oral sensorial products including stain inhibitor
US20120247492A1 (en) * 2010-03-26 2012-10-04 Philip Morris Usa Inc. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
US20110247640A1 (en) * 2010-04-08 2011-10-13 R. J. Reynolds Tobacco Company Smokeless Tobacco Composition Comprising Tobacco-Derived Material and Non-Tobacco Plant Material
US20110303232A1 (en) * 2010-04-12 2011-12-15 Altria Client Services Inc. Pouch product with improved seal and method
US20120042883A1 (en) * 2010-08-17 2012-02-23 Internationl Oddities, Inc. Composite Packaging System For Particulate Smokable Product
US20120067362A1 (en) * 2010-09-13 2012-03-22 Michele Mola Smokeless Oral Products
US20120103353A1 (en) * 2010-11-01 2012-05-03 Sebastian Andries D Smokeless tobacco products
US20120291793A1 (en) * 2011-05-19 2012-11-22 R.J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
US20130152953A1 (en) * 2011-12-14 2013-06-20 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US20140271791A1 (en) * 2013-03-15 2014-09-18 Altria Client Services Inc. Oral energy products including encapsulated caffeine
US20140261480A1 (en) * 2013-03-15 2014-09-18 Altria Client Services Inc. Pouch material for smokeless tobacco and tobacco substitute products

Cited By (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973256B2 (en) 2012-07-30 2021-04-13 British American Tobacco (Investments) Limited Fleece for smokeless tobacco
USD777975S1 (en) * 2012-07-30 2017-01-31 British American Tobacco (Investments) Limited Tobacco pouch
USD777974S1 (en) * 2012-07-30 2017-01-31 British American Tobacco (Investments) Limited Tobacco pouch
USD780989S1 (en) * 2012-07-30 2017-03-07 British American Tobacco (Investments) Limited Tobacco pouch
US9913491B2 (en) 2012-07-30 2018-03-13 British American Tobacco (Investments) Limited Fleece for smokeless tobacco
US20160128294A1 (en) * 2014-11-10 2016-05-12 R.J. Reynolds Tobacco Company Infused plant seeds
US11832640B2 (en) 2014-12-05 2023-12-05 R.J. Reynolds Tobacco Company Capsule-containing pouched product for oral use
USD837447S1 (en) * 2015-04-17 2019-01-01 Swedish Match North Europe Ab Oral snuff package
US20180140007A1 (en) * 2015-04-17 2018-05-24 Swedish Match North Europe Ab Oral pouched product having a rectangular shape
USD868369S1 (en) * 2015-12-02 2019-11-26 Swedish Match North Europe Ab Snuff pouch
US11794985B2 (en) * 2016-04-29 2023-10-24 Ahlstrom Oyj Compostable lid intended to seal a capsule and a capsule sealed by the lid
US11993449B2 (en) 2016-04-29 2024-05-28 Ahlstrom Oyj Compostable lid intended to seal a capsule and a capsule sealed by the lid
WO2018092035A1 (fr) 2016-11-15 2018-05-24 Rai Strategic Holdings, Inc. Communication en champ proche pour un article à base de tabac ou son emballage
EP4016422A1 (fr) 2016-11-15 2022-06-22 RAI Strategic Holdings, Inc. Communication en champ proche pour un article à base de tabac ou son emballage
US20180279673A1 (en) * 2017-03-29 2018-10-04 Rai Strategic Holdings, Inc. Aerosol delivery device including substrate with improved absorbency properties
US10440995B2 (en) * 2017-03-29 2019-10-15 Rai Strategic Holdings, Inc. Aerosol delivery device including substrate with improved absorbency properties
US12344459B2 (en) 2017-04-28 2025-07-01 Ahlstrom Oyj Compostable lid comprising an oxygen barrier layer for sealing a capsule and capsule sealed by the lid
US11844368B2 (en) 2017-12-15 2023-12-19 Swedish Match North Europe Ab Flavoured moist oral pouched nicotine product comprising monoglyceride
EP3784064B1 (fr) 2019-03-18 2021-06-02 Swedish Match North Europe AB Matériau d'emballage et produit à base de nicotine en sachet destiné à être administré par voie orale
WO2021050741A1 (fr) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Produit oral comprenant une amine basique et un agent d'appariement d'ions
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
WO2021048791A1 (fr) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Produits en sachet à stabilité de saveur améliorée
EP4285743A2 (fr) 2019-09-11 2023-12-06 Nicoventures Trading Limited Produit oral comprenant une amine basique et un agent d'appariement d'ions
WO2021048770A1 (fr) 2019-09-11 2021-03-18 Nicoventures Trading Limited Procédés alternatifs de blanchiment du tabac
WO2021048768A1 (fr) 2019-09-11 2021-03-18 Nicoventures Trading Limited Procédé de blanchiment de tabac
WO2021048769A1 (fr) 2019-09-13 2021-03-18 Nicoventures Trading Limited Procédé de blanchiment de tabac
WO2021086367A1 (fr) 2019-10-31 2021-05-06 Nicoventures Trading Limited Produit oral et son procédé de fabrication
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
EP4533963A2 (fr) 2019-12-09 2025-04-09 Nicoventures Trading Limited Compositions orales humides
WO2021116867A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions à usage oral tamponnées
WO2021116837A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits en sachet
WO2021116862A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales à teneur en eau réduite
WO2021116895A2 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Sachet sensible à un stimulus
WO2021116868A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à libération contrôlée
WO2021116878A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à liaison améliorée d'ingrédients actifs
WO2021116822A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits oraux à irritation réduite
WO2021116841A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales humides
WO2021116884A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nappe en couches pour produit en sachet
WO2021116842A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits à usage oral à libération contrôlée
WO2021116825A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral
WO2021116827A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Procédé
WO2021116856A2 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits à usage oral
WO2021116916A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit oral avec de multiples arômes ayant différents profils de libération
WO2021116881A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral en sachet poreux comprenant un matériau non-tissé
WO2021116917A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition orale à base de cellulose nanocristalline
WO2021116876A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition à usage oral avec inclusion de sel
WO2021116866A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produits en sachet à stabilité de saveur améliorée
WO2021116865A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents pour composition orale
WO2021116879A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition à usage oral comprenant une substance de betterave
US12491250B2 (en) * 2019-12-09 2025-12-09 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US12471618B2 (en) 2019-12-09 2025-11-18 Nicoventures Trading Limited Stimulus-responsive pouch
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
EP4578301A2 (fr) 2019-12-09 2025-07-02 Nicoventures Trading Limited Produits oraux
US20210169125A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral products with controlled release
WO2021116919A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Non-tissé pour produit oral avec composant libérable
US20220295861A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US20220295874A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral product with sustained flavor release
US20210169138A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
US12318479B2 (en) 2019-12-09 2025-06-03 Nicoventures Trading Limited Process of making nanoemulsion
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
EP4549642A2 (fr) 2019-12-09 2025-05-07 Nicoventures Trading Limited Voile pour produit oral avec composant libérable
WO2021116892A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales à activité de l'eau réduite
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
EP4072347B1 (fr) 2019-12-09 2025-02-12 Nicoventures Trading Limited Non-tissé pour produit oral avec composant libérable
US20210170031A1 (en) * 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US12178905B2 (en) 2019-12-09 2024-12-31 Nicoventures Trading Limited Fleece for pouched product with controlled basis weight
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
EP4072330B1 (fr) 2019-12-09 2024-12-11 Nicoventures Trading Limited Produits oraux à irritation réduite
EP4072332B1 (fr) 2019-12-09 2024-12-11 Nicoventures Trading Limited Compositions orales humides
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
WO2021116918A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Compositions orales comprenant des gels
WO2021116890A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Composition liquide à utilisation orale ou destinée à être utilisée dans un dispositif de distribution d'aérosol
US11826462B2 (en) * 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
WO2021116824A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral comprenant un cannabinoïde
WO2021116834A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nanoémulsion à usage oral
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
WO2021116826A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit à usage oral comprenant un cannabinoïde
US12138342B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Fleece for oral product with releasable component
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11896711B2 (en) 2019-12-09 2024-02-13 Nicoventures Trading Limited Process of making nanoemulsion
EP4072350A4 (fr) * 2019-12-09 2024-03-06 Nicoventures Trading Limited Produits en sachet
US12064424B2 (en) 2019-12-09 2024-08-20 Nicoventures Trading Limited Moist oral compositions
WO2021116823A1 (fr) 2019-12-09 2021-06-17 Nicoventures Trading Limited Produit oral
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
WO2021171185A1 (fr) 2020-02-24 2021-09-02 Nicoventures Trading Limited Matériau de tabac sous forme de billes et procédé de fabrication associé
US12369615B2 (en) * 2020-04-27 2025-07-29 Nonwovenn Ltd Nonwoven fabric for oral pouched product, and methods of manufacturing a nonwoven fabric
US20230180816A1 (en) * 2020-04-27 2023-06-15 Nonwovenn Ltd Nonwoven fabric for oral pouched product, and methods of manufacturing a nonwoven fabric
JP2023528847A (ja) * 2020-06-03 2023-07-06 スウィーディッシュ・マッチ・ノース・ヨーロップ・アーベー 包装材料及び経口用袋状製品
WO2021244892A1 (fr) * 2020-06-03 2021-12-09 Swedish Match North Europe Ab Matériau d'emballage et produit en sachet pour utilisation par voie orale
WO2021250516A1 (fr) 2020-06-08 2021-12-16 Nicoventures Trading Limited Composition orale effervescente comprenant un principe actif
US12274779B2 (en) 2020-06-08 2025-04-15 Nicoventures Trading Limited Effervescent oral composition
US12441534B2 (en) * 2020-07-30 2025-10-14 Tenowo GmbH Moisture-permeable, microporous luxury food packaging material made of nonwoven fabric
US20230249899A1 (en) * 2020-07-30 2023-08-10 Tenowo GmbH Moisture-permeable, microporous luxury food packaging material made of nonwoven fabric
WO2022043700A1 (fr) 2020-08-27 2022-03-03 Nicoventures Trading Limited Produit oral
WO2022049536A1 (fr) 2020-09-04 2022-03-10 Nicoventures Trading Limited Procédé de blanchissement de tabac
WO2022053982A1 (fr) 2020-09-11 2022-03-17 Nicoventures Trading Limited Substrats à base d'alginate
EP3992093B1 (fr) 2020-10-29 2023-06-07 Swedish Match North Europe AB Produit à usage oral en sachet, procédé d'étanchéité, dispositif d'étanchéité, procédé et appareil de fabrication d'un produit à usage oral en sachet
WO2022107031A1 (fr) 2020-11-19 2022-05-27 Nicoventures Trading Limited Produits à usage oral
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US12496276B2 (en) 2021-02-09 2025-12-16 Nicoventures Trading Limited Agents for oral composition
WO2022229929A1 (fr) 2021-04-30 2022-11-03 Nicoventures Trading Limited Produits destinés à être administrés par voie orale à charge de haute densité
USD1049470S1 (en) 2021-05-05 2024-10-29 Lucy Goods Inc. Nicotine pouch
WO2022234522A1 (fr) 2021-05-06 2022-11-10 Nicoventures Trading Limited Compositions orales et procédés associés pour réduire l'irritation de la gorge
WO2022264066A1 (fr) 2021-06-16 2022-12-22 Nicoventures Trading Limited Produit en sachet comprenant une composition soluble
WO2022269556A1 (fr) 2021-06-25 2022-12-29 Nicoventures Trading Limited Produits pour voie buccale et procédé de fabrication
US12382982B2 (en) 2021-06-25 2025-08-12 Nicoventures Trading Limited Oral products and method of manufacture
WO2023281469A1 (fr) 2021-07-09 2023-01-12 Nicoventures Trading Limited Structures extrudées
US12310394B2 (en) 2021-07-30 2025-05-27 Nicoventures Trading Limited Aerosol-generating substrate comprising microcrystalline cellulose
WO2023053062A1 (fr) 2021-09-30 2023-04-06 Nicoventures Trading Limited Produit oral comprenant une amine basique et un agent d'appariement d'ions
US20230292827A1 (en) * 2022-03-21 2023-09-21 Lucy Goods, Inc. Nicotine pouch with capsule having mct oil
WO2023187675A1 (fr) 2022-03-31 2023-10-05 R. J. Reynolds Tobacco Company Matériau botanique aggloméré pour produits oraux
WO2023248187A1 (fr) 2022-06-24 2023-12-28 Nicoventures Trading Limited Composition orale comprenant un modulateur de récepteur
WO2024074834A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074836A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074839A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit oral
WO2024074843A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit à administration par voie orale
WO2024074835A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit destiné à la voie orale
WO2024074842A1 (fr) 2022-10-07 2024-04-11 Nicoventures Trading Limited Produit à administration par voie orale
WO2024079722A1 (fr) * 2022-10-14 2024-04-18 Nicoventures Trading Limited Produits en sachet contenant des capsules
WO2024095163A1 (fr) 2022-11-01 2024-05-10 Nicoventures Trading Limited Composition orale comprenant un agent d'ajustement de ph encapsulé
WO2024095162A1 (fr) 2022-11-01 2024-05-10 Nicoventures Trading Limited Procédé de préparation d'un produit en sachet comprenant un sel de nicotine
WO2024095013A1 (fr) 2022-11-04 2024-05-10 Nicoventures Trading Limited Produit à administration orale
WO2024095011A1 (fr) 2022-11-04 2024-05-10 Nicoventures Trading Limited Produit à administration par voie orale
WO2024171117A1 (fr) 2023-02-15 2024-08-22 Nicoventures Trading Limited Produits oraux à charge de haute densité
WO2024180481A1 (fr) 2023-02-28 2024-09-06 Nicoventures Trading Limited Produit à prendre par voie orale contenant de la caféine
WO2024201031A1 (fr) 2023-03-27 2024-10-03 Nicoventures Trading Limited Produit oral pour l'administration d'agents actifs
WO2024236293A1 (fr) 2023-05-16 2024-11-21 Nicoventures Trading Limited Produit oral
WO2024236294A1 (fr) 2023-05-16 2024-11-21 Nicoventures Trading Limited Produit à administration par voie orale
WO2025141419A1 (fr) 2023-12-28 2025-07-03 American Snuff Company, Llc Procédé de fermentation en masses de tabac
EP4585059A1 (fr) 2024-01-12 2025-07-16 Nicoventures Trading Limited Produit effervescent en sachet
WO2025149968A1 (fr) 2024-01-12 2025-07-17 Nicoventures Trading Limited Produit en sachet effervescent
WO2025168836A1 (fr) * 2024-02-09 2025-08-14 Pely-Tex Gmbh & Co. Kg Sac comprenant une enveloppe de sac constituée d'un non-tissé perméable à l'eau et/ou perméable à la vapeur d'eau et matériau de remplissage disposé à l'intérieur pour application orale ou autres applications avec libération contrôlée de substances actives et procédé de production d'un tel sac
EP4600415A1 (fr) * 2024-02-09 2025-08-13 pely-tex GmbH & Co. KG Sachet comprenant une enveloppe en non-tissé perméable à l'eau et/ou à la vapeur d'eau et un matériau de remplissage pour application orale ou autres applications à libération contrôlée de principes actifs et procédé de fabrication d'un tel sachet
EP4623702A1 (fr) 2024-03-27 2025-10-01 Nicoventures Trading Limited Produit oral
WO2025202624A1 (fr) 2024-03-27 2025-10-02 Nicoventures Trading Limited Produit à administration par voie orale
WO2025215370A1 (fr) 2024-04-12 2025-10-16 Nicoventures Trading Limited Utilisation de flavones telles que la quercétine pour augmenter la fonction cognitive et pour réduire l'agitation
EP4631502A1 (fr) 2024-04-12 2025-10-15 Nicoventures Trading Limited Utilisation de flavones telles que la quercétine pour augmenter la fonction cognitive et réduire la nervosité
EP4640076A1 (fr) 2024-04-22 2025-10-29 Nicoventures Trading Limited Produit oral avec émulsion d'arôme
EP4640075A1 (fr) 2024-04-22 2025-10-29 Nicoventures Trading Limited Produit en sachet oral avec système d'administration auto-émulsifiant
WO2025224592A1 (fr) 2024-04-22 2025-10-30 Nicoventures Trading Limited Produit en sachet destiné à être administré par voie orale à système d'administration auto-émulsifiant
WO2025224591A1 (fr) 2024-04-22 2025-10-30 Nicoventures Trading Limited Produit oral à émulsion d'arôme
EP4640072A1 (fr) 2024-04-24 2025-10-29 Nicoventures Trading Limited Tissus non tissés traités avec un agent d'appariement d'ions et produits oraux comprenant des tissus non tissés traités avec un agent d'appariement d'ions

Also Published As

Publication number Publication date
JP2017536129A (ja) 2017-12-07
JP2024105405A (ja) 2024-08-06
US20220264931A1 (en) 2022-08-25
EP3226700B1 (fr) 2024-07-10
JP6854760B2 (ja) 2021-04-07
JP7485628B2 (ja) 2024-05-16
EP4442128A1 (fr) 2024-10-09
JP2021097704A (ja) 2021-07-01
DK3226700T3 (da) 2024-08-12
EP3226700A1 (fr) 2017-10-11
US20220030928A1 (en) 2022-02-03
CN107205471A (zh) 2017-09-26
US11344057B2 (en) 2022-05-31
WO2016090075A1 (fr) 2016-06-09
US20240074481A1 (en) 2024-03-07
US11832640B2 (en) 2023-12-05
CN115517405A (zh) 2022-12-27

Similar Documents

Publication Publication Date Title
US11832640B2 (en) Capsule-containing pouched product for oral use
JP7655952B2 (ja) 物品
EP4073307B1 (fr) Produit en sachet
US20160000140A1 (en) Oral pouch products
US20210204590A1 (en) Pouched products
CA3159813A1 (fr) Produit oral a composant soluble
US20220225660A1 (en) Pouched products with heat sealable binder
US20210204585A1 (en) Pouched products with heat sealable binder
US20220232881A1 (en) Method for sealing pouches
EP4503974A1 (fr) Produits en sachet avec liant thermoscellable
JP2025510884A (ja) エアロゾル生成組成物及びその使用
JP2025510879A (ja) 支持体上にエアロゾル生成材料を含む基材及びその使用
JP2022086451A (ja) 喫煙具用カートリッジ

Legal Events

Date Code Title Description
AS Assignment

Owner name: R.J. REYNOLDS TOBACCO COMPANY, NORTH CAROLINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHAPMAN, PAUL STUART;TURFLER, DAVID TROY;SIGNING DATES FROM 20141216 TO 20150112;REEL/FRAME:034709/0354

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCV Information on status: appeal procedure

Free format text: APPEAL BRIEF (OR SUPPLEMENTAL BRIEF) ENTERED AND FORWARDED TO EXAMINER

STCV Information on status: appeal procedure

Free format text: EXAMINER'S ANSWER TO APPEAL BRIEF COUNTED

STCV Information on status: appeal procedure

Free format text: EXAMINER'S ANSWER TO APPEAL BRIEF MAILED

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION